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Abstract 
 
Mycobacterium tuberculosis is a serious health problem worldwide, and cannot be conquered 
without an efficient vaccination strategy. Today there are no efficient vaccines available, and it 
is thereby urgent to develop new ones. M. tuberculosis is also acquiring resistance to an 
increasing number of antibiotics, which has even lead to a M. tuberculosis strain that is totally 
drug-resistant. Consequently, it is crucial to develop new drugs to deal with this threat. To 
develop new vaccines and drugs it is important to identify and validate new potential 
mycobacterial drug targets.  
Mycobacterium avium shares many properties with its relative M. tuberculosis, such as ability 
to establish infection within macrophages. M. avium can also cause severe infections, 
particularly in immunocompromised individuals. Although M. avium can serve as a model 
organism for studying tuberculosis, it is therefore also a bacterium that absolutely needs 
research attention by its own. 
To contribute towards the development of new and effective drugs and vaccines against 
pathogenic mycobacteria, the specific aim of this study was first of all to organise an M. avium 
transposon mutant library of around 10 000 mutants, and prepare it for Illumina sequencing, in 
a way that mutants with specific insertion sites could be easily identified in a future application 
of the library. Such an organised library would make it easy to pick out interesting mutants for 
further investigation and also to conduct screenings of many thousand mutants at the same time 
and study their phenotype under different conditions. 
Secondly, this study aims to investigate selected genes potentially involved to mycobacterial 
iron uptake. In drug development it would be of interest to target parts of the mycobacterial 
iron uptake system, which is essential for the mycobacteria to survive. For this aim, growth 
curve analysis of non-pathogenic model organism Mycobacterium smegmatis with gene 
potentially involved in iron uptake knocked out were performed in media containing various 
iron concentrations. 
Mutants organised and prepared for Illumina sequencing were sent for Illumina sequencing at 
Texas A&M University, and sequencing results are expected to ready at the end of June 2015.  
From the growth curve analysis performed, the result is that the genes msmeg_4898 and 
msmeg_4900 do not seem to be important for the mycobactin pathway in M. smegmatis. 
However, this does not mean that they are not important for this purpose in other mycobacteria. 
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1. Introduction 
1.1 The genus Mycobacterium 
The bacterial genus Mycobacterium consists of aerobic, acid-fast, non-spore-forming rod 
shaped bacteria with a complex and lipid-rich cell wall. They are 0.2 to 0.6 µm wide and 1 to 
10 µm long [1]. Mycobacteria are also non-motile, except for the motile species Mycobacterium 
marinum, which can propel by actin-based motility [2]. In addition most of the mycobacteria 
are slow-growing, dividing every 12 to 24 hours [1].  
 
1.1.1 Mycobacterium tuberculosis 
Mycobacterium tuberculosis, which causes tuberculosis (TB), was responsible for 1.5 million 
deaths and an estimate of  9 million new TB cases in 2013 [3]. This makes tuberculosis a serious 
health problem worldwide. Individuals with HIV currently have TB as the main cause of death 
[4]. Mycobacteria can establish infections within the human macrophage cells, which are the 
first line of defence in the immune system [5]. M. tuberculosis, which is spread through 
infectious aerosols, mostly affect the lungs, but can also infect other parts of the body [6]. In 
some cases the infection is latent, in which cause the infected TB-patients do not show 
symptoms [7].  
The genomic DNA of M. tuberculosis encodes around 4000 genes [8]. It is also surrounded by 
a wax-rich and thick cell wall [6]. This unique cell wall prevents the bacteria from being 
attacked by medical drugs [9]. It also impair nutrient entry into the bacteria, which explains the 
slow growth [10].  
Tuberculosis cannot be conquered without an efficient vaccination strategy [6]. Today there are 
no efficient vaccines, and the need to develop new vaccines is urgent. The vaccine that is used 
today, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), gives good protection against 
severe forms of childhood tuberculosis. However, it does not give protection against adult 
pulmonary tuberculosis, which is the most common form of the disease [11]. 
Also the treatment of tuberculosis faces major challenges. M. tuberculosis is acquiring 
resistance to an increasing number of antibiotics, which has even lead to a totally drug-resistant 
strain of the bacterium [12]. Consequently, it is enormously important to develop new drugs to 
deal with this threat. To manage this, new potential drug targets have to be identified.  
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1.1.2 Mycobacterium avium 
Mycobacterium avium is a bacterium with around 5100 genes, where approximately 2900 of 
these are homologues to genes in M. tuberculosis. M. avium shares many properties with its 
relative, such as ability to establish infection within macrophages and a slow growth rate [13]. 
M. avium is an opportunistic human pathogen, less pathogenic than its relative M. tuberculosis, 
and working with this species requires less stringent biosafety laboratory-levels [14]. 
Infection with M. avium is primarily acquired through ingestion of contaminated food or water. 
Immunocompromised individuals, particularly people living with AIDS, have the greatest risk 
for disease caused by M. avium and an infection can be a severe threat for such patients. This 
is because the infection is typically disseminated if left untreated, with virtually no organ 
saved [1]. Although M. avium can cause severe infections that can be hard to treat, and thus 
deservers research attention by its own, the species have many features in common with M. 
tuberculosis and can serve as a model organism for studying TB [14]. 
 
1.1.3 Mycobacterium smegmatis 
Mycobacterium smegmatis is an often used model organism in M. tuberculosis research, and is 
used to study basic mycobacterial mechanisms. It is saprophytic [15], and contains of around 
7000 genes, where 2700 of these genes are homologues to genes in M. tuberculosis [16]. The 
advantages of M. smegmatis as a model organism is that it is fast-growing and non-pathogenic 
[17].  
 
1.2 Mycobacterial iron uptake 
One of the ways the M. tuberculosis survives intercellularly is by employing mechanisms that 
take up iron at extremely low iron conditions [18]. 
There is a fight for iron between the human cells and the mycobacteria during infection. The 
human body will withhold iron from the mycobacteria. This is done by keeping the level of 
soluble iron low. The extracellular iron is mostly bound to the glycoprotein transferrin, and the 
intracellular iron is bound to ferritin or in a complex with heme, e.g. haemoglobin [19]. 
Normally transferrin binds only an average of 0.4 atoms of iron per molecule, even though it 
can bind up to 2 atoms per molecule. This leaves room for further iron restriction, so upon 
infections the soluble iron level becomes even lower [20]. 
INTRODUCTION 
3 
 
The mycobacteria on their side have evolved strategies to take up iron even under conditions 
with extremely low levels of iron. These uptake strategies can be divided into three groups; 
using receptors for acquisition of iron bound to transferrin and lactoferrin, heme acquisition 
systems and siderophore-based iron uptake systems [19]. 
 
1.2.1 Mycobacterial siderophores 
Siderophores are iron-binding molecules which transfer iron from ferritin, lactoferrin and 
transferrin to the mycobacterial cell wall [21, 22]. Siderophores are synthesised in the 
cytoplasm transported out of the bacterial cell where they can find and bind iron, before 
transported back into the cell for usage [23]. However, the siderophores are too large to pass 
porins in the membrane. Therefore a special transport system is required for importing and 
exporting siderophores over the outer membrane [24].  
Mycobactin and carboxymycobactin are two structurally related siderophores produced by most 
species of mycobacteria [25]. The only difference between mycobactin and carboxymycobactin 
is that mycobactin has a long monocarboxyl fatty acid tail, while carboxymycobactin has a 
shorter dicarboxyl fatty acid tail [26]. Due to the long fatty acid tail, mycobactin is lipophilic, 
which promotes adherence to the lipidic surface of the mycobacteria. Carboxymycobactin on 
the other hand is hydrophilic because of the short dicarboxyl tail [27]. Mycobactin is proposed 
to be an iron storage molecule, that efficiently extracts intracellular iron from macrophages 
[28].  
In addition to mycobactins, some mycobacteria produce a water-soluble siderophore called 
exochelin. M. smegmatis is one of the mycobacteria producing this siderophore [29]. The fact 
that M. smegmatis has two unrelated siderophore-mediated iron uptake mechanisms can be used 
to find out if a gene is involved in uptake of iron in the mycobactin or exochelin siderophore 
pathway. To determine if a M. smegmatis gene is involved in the mycobactin pathway can 
potentially be translatable to iron uptake in pathogenic mycobacteria. In fact, the gene cluster 
esx-3 was found to be required for mycobactin-mediated iron uptake using the M. smegmatis 
approach [30], however why it is required is still not known. The gene cluster esx-3 was found 
to be required for mycobactin-mediated iron uptake by combining mutations in the two different 
iron uptake pathways. The bacteria should fail to grow under low iron conditions if both 
siderophore pathways are knocked out. By combining mutations in the same iron uptake 
system, the bacteria should still be able to grow under low iron conditions, as it would be 
rescued by the intact siderophore. If a mutant strain where exochelin and another gene of 
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interest are knocked out fails to grow at low iron conditions, this indicates that the gene under 
investigation is important for the mycobactin pathway. Actually, this example is of real interest. 
Today it is not known how mycobactin is transported over the outer membrane (Figure 1) [23]. 
 
 
Figure 1: Model of mycobactin (MBT)/carboxymycobactin (cMBT) transport over the cell wall in M. tuberculosis. 
To export mycobactin and carboxymycobactin across the cell wall a yet undiscovered protein in the outer membrane is required. 
To transport the siderophores with bound iron across the outer membrane a siderophore receptor in the outer membrane is 
required. The proteins required for mycobactin/carboxymycobactin transport over the outer membrane in the cell wall are not 
known [23]. 
 
1.2.2 Putative iron uptake genes msmeg_4898 and msmeg_4900 
The M. smegmatis genes msmeg_4898 and msmeg_4900 are homologous genes of lprD and 
rv1342c respectively in M. tuberculosis (Figure 2 and 3). The functions of msmeg_4898 and 
msmeg_4900 is so far unknown. The genes lprD and Rv1342c are identified as encoding 
membrane proteins involved in the cell wall and in cell processes, but their function is not 
further clarified yet [31]. Right upstream of lprD and Rv1342c are the genes mbtM, mbtL, mbtN 
and mbtK (Figure 2), which are known to be involved in mycobactin synthesis in 
M. tuberculosis [32]. The upstream DNA sequence of the gene lprD is also predicted to be a 
binding site for IdeR (iron-dependent regulator), which controls transcription of genes involved 
in iron uptake [33, 34], and it has been shown that lprD is repressed by iron and IdeR [35]. 
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Because of this the genes msmeg_4898 and msmeg_4900, which are probably transcribed 
together, are of interest to study; they can be candidates that can answer the question of how 
mycobactin is transported over the outer membrane. 
 
Figure 2: The genes lprD and rv1342c in M .tuberculosis. 
The M. smegmatis genes msmeg_4898 and msmeg_4900 are homologous genes of lprD and rv1342c respectively in M. 
tuberculosis. Right upstream of lprD and Rv1342c are the genes mbtM, mbtL, mbtN and mbtK, which are known to be involved 
in mycobactin synthesis in M. tuberculosis [36].  
 
Figure 3: The genes msmeg_4898 and msmeg_4900 in M. smegmatis. 
The M. smegmatis genes msmeg_4898 and msmeg_4900 are homologous genes of lprD and rv1342c respectively in M. 
tuberculosis. The genes msmeg_4898 and msmeg_4900 have both an unknown function [37]. 
 
1.3 Mutagenesis as genetic tools for studying gene functions 
In the laboratory, mutagenesis is an important technique to produce mutations in genes. It is 
possible to manipulate different elements in a gene, such as its coding sequence or its control 
elements. By mutating a gene in a way that causes it to lose its original function, the function 
of a gene or protein can be explored. The two common mutagenesis tools used in this project 
were homologous recombination and insertional mutagenesis [38]. Homologous recombination 
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was used to knock-out genes potentially involved in mycobacterial iron uptake (section 4.4) 
and insertional mutagenesis were used to generate a transposon mutant library (section 4.1).  
 
1.3.1 Insertional mutagenesis 
Insertional mutation is when a DNA sequence, such as a transposon, is inserted in the gene to 
be mutated. This will generally lead to a gene disruption, thus supressing expression of the 
affected gene.  
Transposons are DNA sequences which can change position within a genome, and can be 
categorised into two main classes. Class I transposons move by reverse transcription of an RNA 
intermediate. Class II are transposons that move directly from one DNA- sequence to another. 
An overview of how the two classes of transposons are inserted into target DNA is shown in 
Figure 4. Transposons usually have inverted repeats at each end and encode a transposase, 
which is an enzyme that cuts out the transposon sequence and inserts into a new target site [39, 
40]. For most class I transposons insertions occur by replication of a non-moving transposon 
into a different site (Figure 4b). Insertions of class II transposons mostly occur by excision and 
moving to a new site (Figure 4a). With the transposase acting on a specific DNA sequence at 
each end of the transposon, the class II transposon will insert into a new target DNA position. 
This can allow new genes to be transferred to the host’s chromosome [41].  
 
Figure 4: Insertions of class I and class II transposons into target DNA sequences. 
Transposon insertions occur either by  a) excision and movement of the transposon to a new site (mostly class II elements), or 
by b) replication of a non-moving transposon into an additional site (mostly class I elements) [39]. 
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Delivery of a transposon to a cell can be achieved by transformation with plasmid DNA or by 
using a virus. Disruption of a genetic sequence by a transposon can thus be used as a genetic 
tool for analysis of protein and gene function, by using them as vectors for genome 
manipulations [42]. The insertion of a transposon can suppress the natural function of a gene, 
by altering gene expression or regulation [43]. It is then possible to investigate how this loss of 
function affects the organism. This is called transposon mutagenesis and is an effective method 
for creating random mutations at high frequency in target DNA [44]. 
 
1.3.1.1 Transposon mutagenesis of mycobacteria 
Because of the slow growth of mycobacteria and the low availability of refined genetic tools, it 
has generally been difficult to study and identify conditionally essential genes in mycobacteria 
[45]. Transposon mutagenesis is a very important technique for finding such genes, because 
very complex mutant libraries can easily be made [43].  
To insert transposons randomly into mycobacterial genome, the phagemid ϕMycoMarT7 has 
been constructed by Sassetti et al. and shown to be effective for creating mycobacterial insertion 
mutants [45]. This phagemid contains a class II transposon encoding a kanamycin resistance 
gene as well as a highly active Himar1 transposase. At both ends of the transposon there are 29 
base pairs long inverted repeats. Like other Himar1-based transposons, this transposon inserts 
only at dinucleotide TA [45]. An overview of the transposon in ϕMycoMar T7 is shown in 
Figure 5. 
 
Figure 5: An overview of the transposon in ϕMycoMarT7.   
Transposon ϕMycoMarT7 contains a kanamycin resistance gene and each end has inverted repeats. 
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1.3.2 Homologous recombination 
Homologous recombination makes it possible to exchange gene sequences between two DNA 
molecules, and is another valuable mutagenesis technique often used in laboratory DNA 
manipulations. Homologous recombination occurs at low frequencies in human cells, where it 
increases genetic variation during meiosis [46], and can repair double stranded breaks in the 
DNA [47]. Some bacteria use homologous recombination to exchange genetic material between 
strains [48]. 
 
In homologous recombination two DNA-molecules exchange parts of their sequence. To make 
this happen the DNA sequences to be swapped must be similar to each other, which can be done 
by matching flanking areas. A recombinase, an enzyme that catalyse exchange of a DNA, 
recognises and binds the flanking areas [49]. Knock-out mutants can be made by using 
homologous recombination, because the swapping can be used to cut a gene out of a genome, 
and replace it with another DNA sequence, that e.g. could be coding for an antibiotic resistance 
gene. 
 
1.3.2.1 Mycobacterial recombineering plasmid pJV53 
A plasmid used for homologous recombination in mycobacteria is the plasmid pJV53, 
constructed by van Kessel and Hatfull. The plasmid, encodes the recombinase proteins gp60 
and gp61. They are under control of an acetamide-inducible promotor. Gp60 is a 5’-3’ double 
stranded DNA-dependent exonuclease. Gp61 is a single stranded DNA-binding protein which 
promotes annealing of complementary DNA strands, strand exchange and strand invasion [50].  
 
1.4 Illumina Sequencing 
Next-generation sequencing (NGS) technologies became available at the onset of the 21st 
century. NGS sequencing platforms are fast and very efficient. Today NGS technologies are 
used in many fields within biology and they are continually becoming even faster, more 
efficient and cheaper [51]. One of these NGS platforms is Illumina sequencing, which makes it 
possible to sequence a whole mutant library in one run. Also by uniquely labelling the mutants 
it is possible to link the sequencing results to the respective bacteria culture. This is explained 
in more details in section 1.4.3. 
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1.4.1 The principle of Illumina sequencing - sequencing by synthesis 
Illumina technology makes it possible to sequence a high number of samples in parallel. The 
flow cells in the Illumina sequencer are coated with two types of oligonucleotides. The DNA-
fragments in the sample to be sequenced have adapters ligated to both ends of the strands. When 
the sample is loaded onto the flow cell, single-stranded fragments bind randomly to the first of 
the two types of oligonucleotides in the flow cell via a complementary adapter region. The 
bound fragments are then made double-stranded by adding polymerase and nucleotides. The 
double-stranded molecules are then denaturated, and the original template is washed away. The 
single-stranded molecule left behind bends over and the adapter at the other side of the molecule 
binds to the second type of oligonucleotides. This molecule now form a bridge, and the 2nd 
strand is then synthesised. This is called bridge amplification. The molecule is denaturated 
again resulting in two single-stranded copies of the molecule. This is simultaneously repeated 
several times for all the fragments, so that millions of clusters of double stranded DNA will be 
generated. Each cluster contains the amplification products from the one original single-
stranded DNA-fragment. Right before sequencing, the reverse strands are cleaved and washed 
away, so that there are only forward strands left. The 3’end of these strands are blocked to 
prevent additional priming to oligonucleotides. A sequencing primer binds to the single-
stranded molecule and is extended by fluorescently tagged nucleotides, which are competing to 
bind. The complementary nucleotide will bind. After the incorporation of each nucleotide the 
clusters are excited by a laser, and the characteristic fluorescence of the added nucleotide is 
emitted and captured for each cluster. This is repeated several times and this way one nucleotide 
after another in the template is identified. The sequencing results can then be compared to a 
reference genome from a databank [52]. 
1.4.2 Transposon-sequencing (Tn-seq) 
Illumina sequencing can be used to identify where transposons are inserted in a genome by a 
technique called transposon sequencing [53]. This technique can for example be used to identify 
which gene has been knocked out by a transposon insertion. To do this, it is essential to prepare 
the transposon-containing genome before sequencing. The general principle is to use one primer 
that binds to the end of the transposon, and one primer that binds to a ligated adapter at the end 
of the sheared genomic fragment. By PCR, using a high-fidelity polymerase, the genome 
sequence flanking the inserted transposon can thus be specifically amplified before Illumina 
sequencing. The workflow for the preparation of genomic DNA for transposon sequencing is 
presented in Figure 6. 
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Figure 6: Sample preparation for identification of transposon insertion sites using Illumina sequencing. 
To prepare a transposon mutant library for Illumina sequencing the genomic DNA from the mutants must first be sheared. 
Afterwards adaptors have to be ligated to the fragments. In this workflow the adaptors are ligated by first doing end-repair 
and A-tailing. The adaptors are used to facilitate PCR amplification of the fragments containing transposon sequences.  
 
The first step after isolation and purification of the DNA is to shear it into smaller fragments. 
This can be done by using enzymatic or mechanical shearing. To prepare the fragments for 
adaptor attachment, end-repair and A-tailing is carried out (Figure 6). End-repair means the 
repair of the double strand ends after shearing so that all the fragments have blunt ends. The 
following A-tailing adds an extra A to the ends of the fragment. The adaptor has a 
T-overhang, and will then attach to the A-tailed DNA fragment to make an A-T 
complementary binding between the adaptor and the fragments. The adaptors are then used to 
facilitate PCR amplification of the fragments containing transposon sequences. After this 
preparation, massively parallel sequencing is used to determine the location of the transposons 
in the genome studied. At the same time it is possible to determine the relative abundance of 
mutants containing a transposon at particular insertion site [54]. Transposon sequencing has 
previously been performed in M. tuberculosis to identify regions required for growth [55]. 
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1.4.3 Sample multiplexing and barcoding 
To separate different pools of samples, the primers used to amplify DNA before Illumina 
sequencing can have DNA indexes encoded. By adding index reads to the Illumina run 
parameters, these indexes will ensure that the various pools can be separated from each other 
after the end of the run. This strategy is called Illumina multiplexing [56]. Different pools of 
samples can then be analysed in one single run, without much increase in time and cost [57]. 
Furthermore, DNA barcodes can also be incorporated into the adapters, and increase the number 
of pools that can be sequenced and analysed in one single run even further. In this study, to 
identify the transposon insertion sites of around 10 000 M. avium transposon library mutants in 
one single Illumina sequencing run, a dual approach with primer indexing and adapter 
barcoding will be used.  
 
A newly published article in Nature Communications, describes a similar approach as used in 
this thesis to organise a transposon mutant library of the M. bovis BCG vaccine strain by sample 
multiplexing and barcoding of the mutants before Illumina sequencing [58]. 
 
The M. avium transposon library mutants in this thesis were grown in 384-well plates, and then 
these wells were pooled into plate, row and column pools. The primer indexes referred to if the 
mutant was in a plate, row or column pool, while the adapter barcodes were used to define the 
number of the plate, row and column pools. In this way it was possible to identify which well 
the mutant was grown in originally, although all the pools were analysed in one single run.  
 
With a transposon library organised in this manner it is possible to perform large-scale 
screenings and study the phenotype of all or several mutants in the library at the same time. It 
is also possible to pick out a few genes of interest, e.g. genes that might be related to iron uptake. 
After the desired mutant has been isolated, its phenotype can be studied, e.g. to investigate how 
the mutant will grow in media with low and high content of iron.  
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2. Aims of the study 
The overall aim with this study was to contribute to identifying and validating new potential 
mycobacterial drug targets, and by this contribute towards the future development of new and 
effective drugs against pathogenic mycobacteria. 
The specific aims of this study was first of all to organise an M. avium transposon mutant library 
of around 10 000 mutants, and prepare it for Illumina sequencing, in a such way that mutants 
with specific insertion sites could be easily identified in a future application of the library. The 
library will then be a tool for investigating the role of the mutated genes have during infection, 
including the mutants’ ability to survive under different environmental conditions. More 
specifically, such a library could be used e.g. to explore how gene disruptions in M. avium affect 
the bacteria’s ability to survive intracellularly in human macrophages. This kind of research 
will be much easier with an organised mutant library of M. avium available, where it will be 
easy to pick out interesting mutants for further investigation. The library will also make it 
possible to conduct screenings of many thousand mutants at the same time and study their 
phenotype under different conditions. By the fact that M. avium is not particularly susceptible 
for homologues recombination to create targeted knockout mutants, a mutant transposon library 
is also of great value. A scheme over the preparation workflow of transposon library mutant for 
Illumina sequencing, is shown in Figure 7. 
Secondly, this thesis aims to investigate selected genes potentially involved to mycobacterial 
iron uptake, which is essential for the mycobacteria to survive. For this aim, the non-pathogenic 
model organism M. smegmatis, which is susceptible to homologous recombination, will be 
used. Thus, the specific genes of interest can be directly targeted for gene mutagenesis. To 
assess these genes involvement in mycobacterial iron uptake, growth curve analysis of 
recombined M. smegmatis in media containing various iron concentrations will be performed. 
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                9216 mutants/colonies                       24 348-well plates  Pooling of library 
 
 
 
 
 
 
   24 plate pools               24 column pools          16 row pools 
Preparation of pools for Illumina sequencing by DNA 
purification, DNA shearing, end-repair, A-tailing and adapter 
ligation 
Master pools of adapter ligated DNA from 
plates, columns and rows 
1 master plate pool        1 master column pool           1 master row pool 
 
PCR amplification of transposon insertion sites, and then send 
in to Texas A&M University for Illumina sequencing 
Figure 7: A scheme over the preparation workflow of transposon library mutants for Illumina sequencing. 
Using the sequencing results to find 
and pick coded mutants. 
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3. Materials and methods 
 
3.1 Tables of materials 
3.1.1 Growth media 
The growth media used in this study are described in Table 1. 
Table 1: Growth media used in this study. 
Growth media Contents Purpose 
LB – Luria Bertoni 5 g tryptone, 2.5 g yeast extract, 
5 g NaCl. dH2O up to 500 ml. 
Autoclaved. 
Optional: Appropriate 
antibiotics. 
Cultivation of E. coli DH5α 
LB agar 5g tryptone, 2.5 g yeast extract, 
5 g NaCl, 7.5 g agar. dH2O up 
to 500 ml. Autoclaved. 
Optionally: Appropriate 
antibiotics. 
Here 100 µg/ml ampicillin. 
Cultivation of E. coli DH5α 
7H9 Complete 
 
2.35 7H9 broth base, 450 ml 
dH2O, 1.2 ml 85% glycerol. 
After autoclaving: 50 ml ADC 
and 1.25 ml 20 % Tween 80. 
Optional: Appropriate 
antibiotics. 
Cultivation of mycobacteria 
7H10 
 
9.5 g 7H10, 450 ml dH2O, 3 ml 
85% Glycerol. 
After autoclaving; 500 µl 
150 mM FeCl3, 50 ml ADC. 
Optional: Appropriate 
antibiotics. Here 7.5 µg/ml 
gentamicin. 
Cultivation of mycobacteria 
SOC 20 g bacto tryptone, 5 g bacto 
yeast extract, 2 ml of 5M NaCl, 
2.5 ml of 1M KCl, 10 ml of 1M 
MgCl2, 10 ml of 1M MgSO4, 
20ml of 1M glucose. dH2O up 
to 1 litre. 
Transformation recovery 
Chelated Sauton’s 70 ml 85 % glycerol, 0.5 g 
KH2PO4, 2.2 g citric acid 
monohydrate, 4g asparagine, 
10 g chelex. 
Adjust pH to 7.4 with NaOH. 
Stir for in 2-3 days, sterile filter 
and add 1 g MgSO4 and 0.05% 
Tween. 
Growth medium for growth 
curve analyses 
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3.1.2 Buffers and solutions 
The buffers and solutions used in this study are described in Table 2. 
Table 2: Buffers and solutions used in this study. 
Buffers and solutions Contents / Manufacturer Purpose 
PBS  
(Phosphate Buffered Saline)  
Sigma-Aldrich Bacteria medium while bead 
beating 
50 x TAE buffer 
(Tris-Acetate-EDTA buffer) 
242 g Tris base, 57.1 ml 
glacial acetic acid, 37.2 
Na2EDTA∙2H2O 
pH   ̴ 8.5, H2O up to 1 L 
Agarose gel electrophoresis 
6x Orange G Loading Dye 40 mg Orange G, 4 g 
sucrose, 7 ml deionized H2O 
Agarose gel electrophoresis 
Gel Loading Dye, Blue (6X) New England Biolabs Agarose gel electrophoresis 
EDTA 
(Ethylenediaminetetraacetic 
acid) 
Sigma Stopping the activity of 
fragmentase 
Glycerol 85 % Merck Freezing of bacterial stock 
culture. 
Washing of cells before 
electroporation. 
2’2’-dipyridyl Alfa Aesar Iron chelator 
FeCl3 Sigma-Aldrich Sauton’s medium and 7H9 
iron supplement 
ADC (Albumin dextrose 
catalase) 
4.25 g NaCl, 25 g BSA, 
10 g dextrose, 0.015 g 
catalase. Add dH2O up to 
500 ml. Sterile filtrate. 
7H10 medium supplement 
DMSO (Dimethyl sulfoxide) Sigma-Aldrich Inhibit formation of 
secondary structures in 
DNA during PCR.  
 
 
3.1.3 Primers 
All primers used in this study were ordered from Sigma-Aldrich. Primers used to confirm 
presence of kanamycin resistance gene are shown in Table 3. 
Table 3: Primers used in this study to confirm the presence of the kanamycin resistance gene in the transposon library 
mutants. 
Primer Sequence, 5’-3’ 
Kan_F TGGATTGCACGCAGGTTCTC 
Kan_R CGTCAAGAAGGCGATAGAAG 
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Sol_Mar primers are transposon binding primers, that are used in preparation for Illumina 
sequencing. Multiple Sol_Mar primers were mixed to prevent the flow cell image from being 
overwhelmed by simultaneous fluorescence signals from identical first base pairs. Each of the 
four Sol_Mar primers mixed has a different first nucleotide in the variable site and has also a 
distinct length. See Table 4. The Sol_Mar primers were mixed 1:1:1:1 to give a final Sol_Mar 
mix at 10 mM. The transposon homology site shown in Figure 8 is 5 base pair downstream 
from the transposon junction. These 5 remaining base pair are “TGTTA”. 
 
(Attachment homology for Illumina chip; Illumina Read 1 primer; Variable site; transposon 
homology).   
Figure 8: The structure of the transposon primers. 
 
Table 4: The transposon binding primers used in the preparation step for Illumina sequencing.  
The colour coding of the primers is described in Figure 8. 
Primer Sequence, 5’-3’ Purpose 
Sol_Mar_NI GTCTAGAGACCGGGGACTTATC Confirm that the 
adapters are inserted 
in the transposon 
junction and have 
the correct barcode. 
Sol_Mar AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATCTC
GGGGACTTATCAGCCAACC 
Transposon binding 
primer 
Sol_Mar_1b AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATCTT
CGGGGACTTATCAGCCAACC 
Transposon binding 
primer 
Sol_Mar_4b AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATCTG
ATACGGGGACTTATCAGCCAACC 
Transposon binding 
primer 
Sol_Mar_5b AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATCTA
TCTACGGGGACTTATCAGCCAACC 
Transposon binding 
primer 
 
The Sol_AP1-primers bind to the adapters and contain indexes coding for plate, column or 
row (Figure 9). The adapter binding primers used in this study are shown in Table 5. 
(Attachment homology for Illumina chip; Index; Illumina Read 2 primer; adapter homology).   
5’CAAGCAGAAGACGGCATACGAGATNNNNNNNNGTGACTGGAGTTCAGACGTGT
GCTCTTCCGATCTATGATGGCCGGTGGATTTGTG-3’ 
Figure 9: The structure of the adapter primers, Sol_AP1. 
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Table 5: The adapter binding primers used in the preparation step for Illumina sequencing. 
The colour coding of the primers is described in Figure 9. 
Primer Sequence, 5’-3’ Purpose 
Sol_AP1_NI ATGATGGCCGGTGGATTTGTG Confirm that the 
adapters are inserted 
in the transposon 
junction and have 
the correct barcode. 
Sol_AP1_tagged_
57 
CAAGCAGAAGACGGCATACGAGAT 
AAGTAGAGGTGACTGGAGTTCAGACGTGT
GCTCTTCCGATCTATGATGGCCGGTGGATT
TGTG 
Adapter primer: 
Code for plate 
Sol_AP1_tagged_
100 
CAAGCAGAAGACGGCATACGAGAT 
ACACGATCGTGACTGGAGTTCAGACGTGT
GCTCTTCCGATCTATGATGGCCGGTGGATT
TGTG 
Adapter primer: 
Code for column 
Sol_AP1_tagged_
473 
CAAGCAGAAGACGGCATACGAGAT 
CGCGCGGTGTGACTGGAGTTCAGACGTGT
GCTCTTCCGATCTATGATGGCCGGTGGATT
TGTG 
Adapter primer: 
Code for row 
 
The primers used to confirm the knock-out of the genes msmeg_4898 and msmeg_4900 are 
shown in Table 6. 
Table 6: Primers used in this study to confirm knock-out of the genes msmeg_4898 and msmeg_4900. 
Primer Sequence, 5’-3’ 
4898_WT_F CACCTTGGTCAGGCCGAATG 
4898_WT_R TGACGTCGCGGGTGTTGAAGT 
4898_WT_UP_F  AGAAAGAGCAGGACCGATAG 
4898_WT_UP_R TGCGACTTTCGAGGAGAACG 
GENT_KO_F CGTAGCCACCTACTCCCAAC 
GENT_KO_R CACGCATCGTCAGGCATTGG 
 
The sequencing primers used for Sanger sequencing are shown in Table 7. 
 
Table 7: Sequencing primers used in this study. 
Primer Sequence, 5’-3’ Purpose 
Kan_seq2 CTTCCTCGTGCTTTACGG Sanger sequencing to confirm 
that the transposon is inserted 
at different places in the 
genome. 
pJet 1.2 forward 
sequencing 
primer 
CGACTCACTATAGGGAGAGCGGC Sanger sequencing to confirm 
inserts after TA-cloning and 
blunt end cloning. 
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3.1.4 Adapters 
The adapter 1 used in this study was ordered from Invitrogen and the number 2 adapters were 
ordered from Sigma-Aldrich. The barcodes to the number 2 adapters are shown in Table 8. 
Purpose: To code each number of plate, column and row. 
Adapter 1: 5’ – TACCACGACCA-NH2 – 3’ 
Adapter 2: (adapter primer homology; BARCODE ; adapter annealing site) 
5’ – ATGATGGCCGGTGGATTTGTG NNNNNNNN TGGTCGTGGTAT – 3’ 
 
Table 8: The barcodes of the adapters number 2 used in this study. 
Adapter 2 Barcode 
1 ATCACGTT 
2 CGATGTTT 
3 TTAGGCAT 
4 TGACCACT 
5 ACAGTGGT 
6 GCCAATGT 
7 CAGATCTG 
8 ACTTGATG 
9 GATCAGCG 
10 TAGCTTGT 
11 GGCTACAG 
12 CTTGTACT 
13 TGGTTGTT 
14 TCTCGGTT 
15 TAAGCGTT 
16 TCCGTCTT 
17 TGTACCTT 
18 TTCTGTGT 
19 TCTGCTGT 
20 TTGGAGGT 
21 TCGAGCGT 
22 TGATACGT 
23 TGCATAGT 
24 TTGACTCT 
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3.1.5 Ladders 
The ladders used in this study are shown in Figure 10. 
 
 
Figure 10: Ladders used in this thesis.  
1 kb plus DNA ladder from Life Technologies, 1 kb DNA ladder from NEB (New England Biolabs), Generuler 1kb DNA 
ladder from Life Technologies; respectively. 
 
 
3.1.6 PCR kits 
The PCR kits used in this study are shown in Table 9. 
Table 9: PCR kits used in this thesis. 
PCR kit Manufacturer  Purpose 
GoTaq Green Master Mix Promega Finding the gene for 
kanamycin resistance. 
Finding mutants for growth 
curve analysis. 
KOD Xtreme Hot Start 
DNA Polymerase  
Novagen Illumina sequencing 
preparations. 
BigDye Terminator v1.1 
Cycle Sequencing Kit 
Applied Biosystems Preparation for Sanger 
sequencing 
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3.1.7 Cloning kits 
The cloning kits used in this study are shown in Table 10. 
Table 10: Cloning kits used in this thesis 
Cloning kit Manufacturer Purpose 
InsTAclone PCR Cloning 
Kit 
Thermo Scientific TA-cloning 
CloneJET PCR Cloning 
Kit 
Thermo Scientific Blunt cloning 
 
The protocols and tables (Table 11 and 12) under are based on the protocols from the 
manufacturer and adapted to what was done in the laboratory. The ligation mixture was 
immediately after cloning used for transformation. 
 
3.1.7.1 InsTAclone PCR Cloning Kit 
Table 11: The set up for the ligation reaction when using InsTAclone PCR Cloning Kit. 
Component Volume 
5x Reaction Buffer 6 µl 
Non-purified PCR product 1 µl 
Vector pTZ57R/T 0.5 µl 
Nuclease free H2O 19 µl 
T4 DNA ligase 1 µl 
Total volume 30 µl 
 
The control was made by adding nuclease free water instead of PCR-product. The ligation 
reaction was briefly mixed by a vortexer and then centrifuge for 5 seconds. The ligation mixture 
was then incubated over night at 4 °C.  
3.1.7.2 CloneJET PCR Cloning Kit 
Table 12: The set up for the ligation reaction when using CloneJET PCR Cloning Kit. 
Component Volume 
2x Reaction Buffer 5 µl 
Non-purified PCR product 0.5 µl 
pJET 1.2 / blunt cloning vector (50 ng/µl) 0.5 µl 
Nuclease free H2O 3.5 µl 
T4 DNA ligase 0.5 µl 
Total volume 10 µl 
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The ligation reaction was set up on ice. The control was made by adding nuclease free water 
instead of PCR-product. The ligation reaction was briefly mixed by a vortexer and then 
centrifuged for 5 seconds. The ligation mixture was then incubated for 30 minutes at room 
temperature.  
3.2 Dilution series to find the amount of bacteria in the transposon library 
A culture was made from the library stock and cultured for 2 weeks. A tenfold sequential 
dilution series reaching from 10-1 to 10-10 was made by diluting the culture in 7H9 Complete.  
The OD600 was measured for the highest dilution to find the OD for the stock solution. By this 
OD and the already known CFU at OD = 1 for the library stock, an estimate of how many 
bacteria would grow on each agar were made. In addition, 100 µl from each dilution were plated 
on 7H10 agar and the amount of bacteria was determined after an incubation time of 3 weeks. 
This was done to control the theoretical calculations.  
For each dilution 3 times 10 µl were separately plated on the same 7H10-agar plate with 
20 µg/ml kanamycin. After three weeks the amount of colonies in each parallel of each agar 
were manually counted. Therefore, only parallels with clearly distinguishable colonies were 
used for calculations. Parallels with only 1 or 2 colonies were not seen as reliable because of 
the low number. The mean value of the colonies per ml was calculated for all the counted 
parallels together and an estimate of the bacteria concentration in the library stock culture was 
found. 
 
3.3 Purification of DNA 
In this study, five different purification kits were used in order to purify DNA from different 
sources and further analysed in different ways. The protocols presented in this section is 
rewritten protocols from the manufacturers. The protocols are adapted to describe how the 
purification was done in the laboratory in this thesis. Before using the first purification kit 
(MasterPure DNA Purification Kit from Epicentre) the bacteria were lysed by bead beating in 
order to get to the DNA. 
 
3.3.1 Bead beating of bacteria 
For each pool of bacteria the respective tubes were centrifuges, and then solved in 600 µl PBS. 
Then this was heat inactivated at 95°C in 20 min, so it would not be infectious anymore. The 
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DNA was relieved by 0,1mm glass beads, that first were autoclaved and cooled down. The 
tubes with the glass beads and the bacteria were bead beaten with the FastPrep-instrument at 
6000 rpm for 45 seconds three times. 
 
3.3.2 MasterPure DNA Purification Kit from Epicentre 
Purpose: To purify DNA from bead beaten bacteria. 
The samples were centrifuged quickly and the supernatant collected. This supernatant was then 
evaporated to a volume of 150 µl. Then 1 µl Protein K diluted into 150 µl of 2XT and C Lysis 
Solution was added to the 150 µl of sample and mixed thoroughly. This mix was incubated at 
65°C for 15 minutes. During this incubation the samples were vortexed every 5 minutes. 
Subsequently, the samples were cooled 37°C and 1µl of 5 µg/µl RNase A was added and then 
everything was mixed. The samples were then placed on ice for 3-5 minutes. Next, 150 µl of 
MPC Protein Precipitation Reagent were added to the lysed sample and vortexed vigorously for 
10 seconds. The debris was centrifuged down at 4°C for 10 minutes at 10 000 g. The supernatant 
was then transferred to a clean Eppendorf tube and the pellet discarded. Then 500 µl of 
isopropanol were added to the recovered supernatant and the tube inverted 30-40 times. The 
DNA was then centrifuges down at 4°C for 10 minutes at 10 000 g. Afterwards, the isopropanol 
was carefully poured off without dislodging the DNA pellet. The pellet was rinsed twice with 
70% ethanol, still being careful to not dislodge the pellet. Finally, all the residual ethanol was 
removed and the DNA resuspended in 35µl sterile and deionised water.  
 
3.3.3 QIAquick PCR Purification Kit 
Purpose: To purify the DNA between each step in the preparation workflow of the mutants 
before Illumina sequencing. 
5 volumes of Buffer PB were added to 1 volume of the PCR sample and mixed. A QIAquick 
spin column was then placed in a provide 2 ml collection tube. To bind DNA, the sample was 
applied to the QIAquick column and centrifuged for 1 minute. Afterwards, the flow-through 
was discarded, and the QIAquick column was placed back into the same tube. 750 µl Buffer PE 
was added to the QIAquick column and centrifuged for 1 minute. Subsequently, the flow-
through was discarded and the QIAquick column was placed back in the same tube. Finally, the 
QIAquick column was placed into a clean 1.5 Eppendorf tube, and the DNA was eluted by 
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adding 50 µl of sterile and deionised water to the centre of the QIAquick membrane, letting the 
column stand for 1 minute and then centrifuging for 1 minutes.  
 
3.3.4 QIAGEN DyeEx 2.0 SpinKit 
Purpose: To remove BigDye from the sequencing reaction before Sanger sequencing. 
First, the spin column was vortexed gently to resuspend its resin. Then the cap of the column 
was loosen a quarter turn to avoid vacuum inside the spin column. The bottom closure of the 
spin column was broken off and the spin column was then placed in a 2 ml collection tube. This 
was then centrifuged at 750 g for 3 minutes. Afterwards, the spin column was transferred to a 
clean Eppendorf tube. The sequencing reaction was carefully applied onto the centre of the 
slanted gel bed surface in the spin column. Subsequently, the spin column in the Eppendorf 
tube was centrifuged for 3 minutes at 750 g. The spin column was then discarded, and the eluate 
in the Eppendorf tube contained the purified DNA. 
 
3.3.5 PureYield Plasmid Miniprep System 
Purpose: To purify plasmid DNA before transformation. 
First, 1.5 ml of bacterial culture was centrifuged for 30 seconds at maximum speed in a 
microsentrifuge. Afterwards, the supernatant was discarded, and an addition 1.5 ml of bacterial 
culture was added to the same tube. This was also centrifuged for 30 seconds at maximum speed 
in a microsentrifuge. 600 µl of water were then added to the cell pellet and this was resuspended 
completely. Next, 100 µl of Cell Lysis Buffer were added and mixed by inverting the tube 6 
times. Then 350 µl of cold (4-8°C) Neutralization Solution were added and mixed thoroughly 
by inverting. This was centrifuged at maximum speed in a microcentrifuge for 3 minutes. 
Subsequently, the supernatant  was transferred to a PureYield Minicolumn without disturbing 
the cell debris pellet. The minicolumn was placed into a Collection Tube and centrifuged at 
maximum speed in a microcentrifuge for 15 seconds. The flow-through was discarded and the 
minicolumn was placed into the same Collection Tube. Afterwards, 200 µl of Endotoxin 
Removal Wash (ERB) were added to the minicolumn, and centrifuged at maximum speed in a 
microcentrifuge for 30 seconds. Then the minicolumn was transferred to a clean 1.5 ml 
Eppendorf tube, and 30 µl of nuclease-free water were directly added to the minicolumn matrix. 
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This was then standing for 1 minute at room temperature. Finally, the tube with the minicolumn 
was centrifuged for 15 seconds to elute the plasmid DNA. 
 
3.3.6 QIAquick Gel Extraction Kit 
Purpose: To purify DNA from agarose gel. 
The tubes, used for storing the gel pieces after cutting them out from the agarose gel, were 
weighted. Then each tube with the gel slice was weighted. By subtracting the weight of the tube 
the weight of the gel slice was found. 3 volumes of Buffer QG were added to 1 volume of gel 
(100 mg  ̴ 100 µl). This was then incubated at 50°C for 10 min or until the gel slice was 
completely dissolved. To help dissolving the gel, the tube was mined by vortexing every 2-3 
minutes during the incubation. After the gel slice was completely dissolved the colour of the 
mixture was checked if it was still yellow. Then 1 gel volume of isopropanol was added to the 
sample and mixed. Next, a QIAquick spin column was placed in a provided 2 ml collection 
tube. To bind DNA, the sample was applied to the QIAquick column and centrifuged for 1 
minute. Afterwards, the flow-through was discarded and the QIAquick column was placed back 
in the same collection tube. To remove all traces of agarose 0.5 ml of Buffer QG was added to 
the QIAquick column and centrifuged for 1 minute. To wash, 0,75 ml of Buffer PE was added 
to the QIAquick column. The column was standing in 5 minutes before it was centrifuged for 
1 minute. Subsequently, the flow-through was discarded and the QIAquick column was 
centrifuged for an additional 1 min at 10 000 g. Finally, the QIAquick column was placed into 
a clean 1.5 Eppendorf tube, and the DNA was eluted by adding 50 µl of sterile and deionised 
water to the centre of the QIAquick membrane, letting the column stand for 1 minute and then 
centrifuging for 1 minutes. 
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3.4 Spectrophotometry 
Spectrophotometry was used to determine the concentration of purified DNA, and also in order 
to determine bacteria concentration in solution. For both instruments, a blank had to be 
measured first, before measuring the samples. The blank is then the solution the DNA and the 
bacteria is in when they are measured, and this is done to subtract the absorbance of this solution 
from what is desired to measure. 
To measure concentration of purified DNA, the compact UV-spectrophotometer NanoDrop 
1000 from Thermo Fischer Scientific was used. Here only 1-2 µl sample is needed for 
measurement.  
DNA concentration is estimated by measuring the absorbance at a wavelength of 260 nm. The 
absorbance of the sample and its DNA concentration, are proportional values. By measuring 
the absorption ratio of 260/280 nm, the protein contamination in the sample can be measured, 
due to proteins maximum absorbance at 280 nm. The 260/280 nm- ratio should generally be 
over 1.8, to be accepted as “pure” for DNA measurements [59]. The DNA concentrations 
measured at NanoDrop were given in ng/µl. 
To measure bacteria concentration, the compact spectrophotometer Ultrospec 10 Cell density 
meter from Amersham Bioscience was used. Bacteria was measured at a wavelength of 600 nm. 
 
3.5 Robots used at SINTEF 
3.5.1 Colony picking robot 
Genetix QPixII with Software QSoft XP Picking. 
Purpose: Pick colonies from 23 x 23 cm agar plates to 384 well plates 
Parameter settings: 
Diameter: 10-14 
Centre Frame: 116- 178 
Roundness: 0.75 
Picking head with 384 pickers used. 
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3.5.2 Pipetting robots 
Biomek NXP – Laboratory  Automation Workstation from Beckman Coulter with software 
Biomek 
Purpose: To fill each well in the 384-well plates with 50 µl 7H9 complete with 20 µg/ml 
kanamycin before picking the colonies with the colony picking robot. 
 
Freedom EVO 200 from TECAN with Software EVOsim. 
Purpose: Pooling the plates into master plates. 3 µl of the bacteria culture from each well in 
plates were pooled into a master plate in the same position as in the original plate. 
 
MultiFlo Dispenser from BioTek with the software Liquid Handling Control. 
Purpose: Adding glycerol into the well in the 384 well plates that were going to be frozen down, 
to make a concentration of 15 % glycerol in each well.  
 
3.6 PCR 
PCR is a method generally used to amplify a predetermined DNA sequences in vitro. This is 
done by specifically designed primers, a thermostable polymerase, deoxynucleotide 
triphosphates (dNTP’s) in addition to the DNA template. These ingredients are mixed together 
with an appropriate buffer in a PCR tube. The PCR amplification starts by denaturation of the 
DNA in the sample by heat (> 94°C), to separate the double helix into single strands. Then the 
primers are hybridised to each strand, by lowering the temperature. This annealing temperature 
is usually set to 40-65°C. Thereafter, the temperature is raised to the optimum of the DNA 
polymerase. In this step new DNA-strands is synthesised using the original or newly 
synthesised DNA-molecule as a template. By repeating these steps in cycles a pre-determined 
number of times, the amount of DNA sequences amplified is increased exponentially [59]. 
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3.6.1 PCR for in-house Sanger sequencing of genomic DNA  
The sequencing reaction mixes and cycling conditions for PCR amplification done in this 
study are shown in Table 13-22. 
Table 13: Sequencing reaction mix for PCR for in-house Sanger sequencing of genomic DNA to identify transposon 
insertion sites. 
Component Volume 
BigDye v.1.1 2 µl 
5 x Buffer 3 µl 
Template 5 µg 
Primer Kan_seq2 3.2 pmol 
dH2O Up to 20 µl 
 
Table 14: Cycling conditions for PCR for in-house Sanger sequencing of genomic DNA to identify transposon 
insertion sites. 
Step Temperature and time 
1. Polymerase activation 95°C for 4 min 
2. Denature 95°C for 30 sec 
3. Annealing 52°C for 30 sec 
4. Extension 60°C for 4 min 
Repeat steps 2-4 60 cycles total 
5. Hold 4°C 
 
3.6.2 Confirming of the presence of the kanamycin resistance gene  
Table 15: Reaction mix for PCR used to confirm the existence of the kanamycin resistance gene in the transposon 
library mutants. 
Component Volume 
2 x GoTaq green master mix 5 µl 
Primer Kan_F 0.5 µl 
Primer Kan_R 0.5 µl 
30-80 ng genomic DNA 0.5 µl 
dH2O 3.5 µl 
Total volume 10 µl 
 
Table 16: Cycling conditions for PCR used to confirm the existence of the kanamycin resistance gene in the 
transposon library mutants. 
Step Temperature and time 
1. Polymerase activation 95°C for 2 min 
2. Denature 95°C for 45 sec 
3. Annealing 58°C for 45 sec 
4. Extension 72°C for 1 min 
Repeat steps 2-4 25 cycles total 
5. Final extension 72°C for 5 min 
6. Hold 4°C 
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3.6.3 Small scale PCR after adapter ligation 
Table 17: Reaction mix for small scale PCR after adapter ligation of the transposon library mutants. 
Component Volume 
2 x Xtreme Buffer 5 µl 
dNTP's (2 mM each) 2 µl 
dH2O variable 
Sol_Mar_NI 0.3 µl 
Sol_AP1_NI 0.3 µl 
Template 20 ng variable 
KOD Xtreme Hot Start DNA Polymerase (1 
U/µl) 
0.2 µl 
Total volume 10 µl 
 
Table 18: Cycling conditions for small scale PCR after adapter ligation of the transposon library mutants. 
Step Temperature and time 
1. Polymerase activation 94°C for 2 min 
2. Denature 98°C for 10 sec 
3. Annealing 59°C for 30 sec 
4. Extension 68°C for 1 min 
Repeat steps 2-4 30 cycles total 
5. Final extension 68°C for 7 min 
6. Hold 4°C 
3.6.4 PCR for addition of Illumina attachment and read homology 
Table 19: Reaction mix for PCR for addition of Illumina attachment and read homology. 
Component Volume 
2 x Xtreme Buffer 5 µl 
dNTP's (2 mM each) 2 µl 
dH2O variable 
Sol_Mar_mix 0.3 µl 
Sol_AP1_57/100/473 0.3 µl 
Template 100 ng variable 
KOD Xtreme Hot Start DNA Polymerase (1 U/µl) 0.2 µl 
Total volume 10 µl 
 
Table 20: Cycling conditions for PCR for addition of Illumina attachment and read homology. 
Step Temperature and time 
1. Polymerase activation 94°C for 2 min 
2. Denature 98°C for 10 sec 
3. Annealing 59°C for 30 sec 
4. Extension 68°C for 1 min 
Repeat steps 2-4 30 cycles total 
5. Final extension 68°C for 7 min 
6. Hold 4°C 
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3.6.5 Confirming knock-out of the genes msmeg_4898 and msmeg_4900  
Table 21: Reaction mix used for confirming knock-out of the genes msmeg_4898 and msmeg_4900 and thereby 
choosing mutants to growth curve analysis. 
Component Volume 
2 x GoTaq green master mix 5 µl 
Forward primer 0.5 µl 
Reverse primer 0.5 µl 
Bacteria culture 0.5 µl 
dH2O 3 µl 
DMSO 0.5 µL 
Total volume 10 µl 
 
Table 22: Cycling conditions used for confirming knock-out of the genes msmeg_4898 and msmeg_4900 and thereby 
choosing mutants to growth curve analysis. 
Step Temperature and time 
1. Polymerase activation 95°C for 2 min 
2. Denature 95°C for 45 sec 
3. Annealing X°C for 45 sec* 
4. Extension 72°C for 1 min 
Repeat steps 2-4 25 cycles total 
5. Final extension 72°C for 5 min 
6. Hold 4°C 
 
*The annealing temperature was set to 5°C below the melting temperature of the primer in the 
primer pair with the lowest melting temperature. 
 
3.7 Gel electrophoresis 
DNA can be detected by using gel electrophoresis, which separates DNA-fragments according 
to size. By supply of voltage, the small fragments are moving fastest, while the bigger fragments 
are hindered by the polymer network in the gel and are thereby moving slower. By using a 
ladder can the base pair length of the DNA also be estimated. The separation occurs by the 
DNA, which has negatively charged phosphates groups, moving toward the positive pole in an 
electrical field [40]. The DNA-fragments in the gel can be visualised by addition of GelRed, 
which will bind to the DNA and fluoresce by UV-light [60]. 
1 % agarose was made by adding 300 µl 1 x TAE buffer (Table 2) to 3 g of SeaKem LE Agarose 
(Lonza). Gels that were used to cut out slices used for further work, were made 2 %. 2 % agarose 
was made by adding 300 µl 1 x TAE buffer to 6 g of SeaKem LE Agarose. The mixture was 
heated in a microwave until boiling three times, to make sure that the agarose was completely 
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dissolved in the buffer. It was stored at around 60°C. 1 µl of GelRed was added and mixed to 
each 50 µl used in a gel. Then the gel was poured out in a gel form with a comb, to polymerise. 
After the gel was polymerised the gel was moved to an electrophoresis tray and covered with 1 
x TAE buffer. The DNA samples were added to the wells and an electric current of 90 volt was 
run though the gel. The DNA in the gel was visualised with Gel Logic 212 PRO using the 
software Carestream Molecular Imaging. 
 
3.8 Preparation of samples for external analysis 
 
3.8.1 GATC-sequencing 
DNA for Sanger sequencing by GATC was send in 5 µl of 80-100ng/µl purified plasmid DNA 
mixed with 5 µl 5 µM of the sequencing primer to the vector used in transformation. 
3.8.2 Preparation Covaris shearing: 
6 µg of purified DNA were diluted in 100 µl dH2O and delivered to the Genomic Core Facility 
at NTNU for mechanical shearing by the Covaris – Focused ultrasonicator M220. 
3.8.3 Preparing for BioAnalyzer 
No preparation was needed before delivering to the Genomic Core Facility at NTNU. 1µl 
sample was needed for analysing at the BioAnalyzer.  
 
3.9 Analysing data from Sanger sequencing 
Clone-Manager was used to align the sequencing data to a predicted premade result. In this way 
it was possible to find the TGTTA-sequence in the transposon, the adapter barcode and the 
adapter primer index. NBCI Nucleotide BLAST was used to find in which gene the transposon 
was inserted. Since the M. avium strain used in the library is not published yet, the strain 
M. avium 104 was used as a reference genome when using BLAST. 
 
3.10 Transformation 
3.10.1 Transformation in competent E. coli DH5α 
Transformation was preformed to deliver plasmid DNA into the bacteria. This was used to 
preform blunt-cloning, TA-cloning and as a step before checking sequencing of fragments 
prepared during the workflow in section 3.12. 
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50 µl competent E. coli DH5α was thawed on ice. 5 µl of 10 to 100 ng DNA were then added 
to the competent cells, and then leaved on ice for 30 minutes. Next, a heat shock at 42°C in 45 
seconds was preformed, and then a rest on ice for 2 minutes. 500 µl pre-heated SOC (Table 1) 
at 37°C were added, and then incubated at 37°C with shaking for 1 hour. After the last 
incubation, the cell mixture was centrifuged for 3 minutes at 1.7 g. The most of the supernatant 
was discarded, and the rest ( ̴ 200 µl) was resuspended. The cell mixture was plated on pre-
heated 37°C plates with antibiotics, and incubated over night at 37°C. 
 
3.10.2 Transformation in M. smegmatis 
It was created a master mix with 1-1.5 µg DNA, in this study PCR-product of a gentamicin 
resistance gene and flaking regions (section 3.12), per 400 µl of competent cells. In this study 
it was created 3 master mixes per mutant condition. 400 µl of the master mix were transferred 
to a pre-cooled 2 mm gap electroporation cuvette and electroporated. The settings for the 
electroporation were 2.5 kV, 1000 Ω and µF. The time constant after electroporation should 
ideally be above 20. 
Afterwards, the electroporated cells were transferred to tubes containing 2 ml 7H9 complete 
without antibiotics. The five tubes per mutant category with electroporated cells were incubated 
for 4 hours, before they were centrifuged and the pellet resuspended in 400 µl 7H9, and plated 
on 4x5 7H10 plated with 7,5 µg/ml gentamicin and 150 µM FeCl3. These plates were incubated 
for 6 day at 37°C. 
 
3.11 Preparation of transposon library mutants for Illumina sequencing 
3.11.1 DNA shearing 
Using an acoustic sonicator; Covaris - Focused ultrasonicator M220 
Parameter setting: 
Duty Cycle: 10 % 
Intensity: 50 
Cycles/ Burst: 200 
Times: 110 s 
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Using NEBNext dsDNA Fragmentase: 
First, the NEBNext Fragmentase was vortexed for 3 seconds, span quickly and placed on ice. 
The reaction mix then mixed is shown in Table 23. 
Table 23: Reaction mix used for fragmentase shearing. 
Component Volume 
DNA 5 µg  1-16 µl 
10X Fragmentase Reaction Buffer v2 2 µl 
Sterile water variable 
Final volume 18 µl 
 
Then 2.0 µl dsDNA Fragmentase were added and the mixture vortexed for 3 seconds. 
Subsequently, the mixture was incubated at 37°C for the optimised time 25 minutes, to generate 
the desired fragment size. To stop the shearing 5 µl of 0.5 M EDTA was added. 
The fragmented DNA was afterwards cleaned up by using QIAquick PCR Purification Kit. 
Protocol is found in section 3.3.3. 
The fragmentation results were checked by using 5 µl of the fragmented DNA at gel 
electrophoresis. See section 3.7. 
 
3.11.2 End-repair 
All the fragmented DNA, ca. 42 µl after gel electrophoresis, was then used for end-repairing. 
The DNA was mixed with 10 µl of NEBNext End Repair Reaction Buffer (10x), 5 µl of 
NEBNext End Repair Enzyme Mix and 43 µl of sterile water, so the final volume would be 
100 µl. This was then incubated at 20°C for 30 minutes. Afterwards, the DNA was purified by 
using QIAquick PCR Purification Kit, and eluted in 46 µl sterile water. 
 
3.11.3 A-tailing 
All the end-repaired and purified DNA was mixed with 5 µl NEBNext dA-Tailing Reaction 
Buffer and 3 µl Klenow Fragment (3’5’ exo¯). The total volume then became 50 µl. This 
mixture was then incubated at 37°C for 30 minutes. Afterwards, the DNA was purified by using 
QIAquick PCR Purification Kit. The DNA was eluted in 50 µl water, which was pre-heated to 
37°C. Then the tube with the QIAquick column was incubated at 37°C for 10 minutes before 
spinning down. 
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3.11.4 Making adapter mix 
To make the adapters (Table 8 in section 3.1.4) the following components were mixed together 
for each type of adapter made: 
- 4 µl 2mm MgCl2 
- 48 µl adapter 1 100 µM 
- 48 µl barcoded adapter 2 100 µM 
 
Annealing conditions: 
95°C for 4 minutes 
1% descent to 20°C 
Hold at 20°C 
 
3.11.5 Adapter ligation 
The A-tailed DNA was concentrated by a rotary evaporator so the volume of the DNA was 
around 11.7 µl. Then 0,8 µl adapter mix, 1.5 µl NEB T4 DNA ligase buffer and 1.0 µl NEB T4 
DNA ligase were added. The mixture was incubated over night at 16°C. After this incubation, 
the ligation reaction was spiked with 1 µl T4 DNA ligase, 1 µl T4 DNA ligase buffer and 8 µl 
water. Subsequently, the ligation mixture was at 16°C for 2 hours. Finally, the DNA was 
purified by using QIAquick PCR Purification Kit. During this purification, the washing buffer 
PE was sitting on column for 10 minutes. The DNA was eluted in 50µl 37°C water, and the 
tube with the QIAquick column was incubated at 37°C for 10 minutes before spinning down. 
Small scale PCR (10µl) where the transposon junctions were amplified, was done for the 
fragments to check that every sample got smears in the right length, and not dimers. Some of 
the samples were sent for Sanger sequencing, to check the adapters, transposon and insertion in 
genes.  
All the plate pools were pooled together, 42 ng, from each pool. 42 ng was chosen because of 
24 samples times 42 ng is around 1000 ng. Then it would be easy to take out volumes of 100 ng, 
for the next PCR to be done. The same was done for all the column pools and the row pools. 
PCR to add the Illumina attachment and read homology was done. The adapter primer annealed 
directly to the adapter and the transposon primer annealed to the transposon. PCR was done 10 
to 11 times for each of the three pools now remaining to ensure that only some fragments were 
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amplified. The PCR products were run at a gel and the fragments from 200 to 400 base pair 
were cut out of the gel and the DNA purified.  
The DNA from the plate pools was then pooled together, and the same was done for the PCR 
product from the column pool and the row pool. Then it was checked if the pools had a smear 
with the base pair length wanted. Around 25 ng in 30 µl was then sent in from each pool. The 
three pools were pooled into one tube when arriving Texas, where it is analysed. 
 
3.12 Homologous recombination of the genes msmeg_4898 and msmeg_4900 
Gentamicin-resistance marker was previously cloned into a plasmid vector in between 200 base 
pair regions flanking the genes msmeg_4898 and msmeg_4900 by Marte Singsås Dragset. The 
resistant marker and the flanking regions were amplified with PCR. The template in the PCR 
tube was digested for 1 hour with DpnI. DpnI is a restriction enzyme cleaving DNA only when 
its recognition site is methylated [61]. Only the template DNA, and not the newly synthesised 
DNA during PCR will be methylated. Therefore, only the template DNA will be digested. The 
PCR product was then purified using QIAquick PCR Purification Kit (See protocol in section 
3.3.3). 
It was then checked if the PCR product had a concentration of at least 200-250 ng/µl. Four 
cultures of M. smegmatis carrying pJV53 was started in 5 ml 7H9 + 20 µg/ml kanamycin. These 
cultures were wild type, mycobactin knock-out, exochelin knock-out and a double knock-out 
of mycobactin and exochelin. These were incubated for 3 days until the cultures reached 
stationary phase. 50 µl, 100 µl and 150 µl from each of the four cultures were inoculated in 25 
ml 7H9 + 20 µg/ml kanamycin. 17 hours later the OD600 of these new cultures were measured. 
And the cultures, one from each mutant type, that were most in the middle on an OD between 
0.3 and 0.8, were chosen. These were then induced with acetamide to a final concentration of 
0.2 % and incubated for three more hours. The cells were then washed 3 times in 25 ml cold 10 
% glycerol to create electrocompetent cells. This was done by first spinning down the cultures 
at 4700 g in 7 minutes at 4°C. Each culture was then resuspended in 1 ml 10 % glycerol, before 
24 ml more were added and everything mixed by inverting the tube. Spin and washing were 
repeated 3 times. It was made sure that everything was kept cold while preparing the competent 
cells. After the last wash, each pellet was resuspended in 2 ml 10 % glycerol.  
Subsequently, transformation with the homologous recombined plasmid was done, as seen in 
section 3.10.2. From each mutant category 16 colonies were then plated over on a 7H10-plate 
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with 7.5µg/ml gentamicin 150 µM FeCl3. 4 days later four of the re-plated colonies in each 
mutant category that had grown up perfectly, were picked. Each were inoculated in 5 ml 7H9 
with 7,5 µg/ml gentamicin and 150 µM FeCl3. 4 days later all of them were checked with primer 
pair number 1, and 1 culture from each mutant category, that the primer pair indicated that the 
gentamicin resistance gene was inserted, was checked further with the primer pairs 2,3 and 4. 
For PCR-protocol see section 3.6.5. 
3.12.1 Growth curves preparations 
The cultures chosen by the primer pairs, were cultured again in 5 ml 7H9 with 7.5 µg/ml 
gentamicin and 150 µM FeCl3 and incubated in 37°C with shaking. After 3 days, they were 
centrifuged at 4754 g in 7 minutes. Each pellet was then washed in 5 ml Sauton’s chelated 
medium / ironfree. Then the cultures were span down again and the pellet resuspended in 5 ml 
Sauton’s ironfree. OD600 were measured for all the cultures. This was done by filling the 
cuvettes with 100 µl of culture and 900 µl of Sauton’s ironfree, and then multiplying the OD 
by 10 to get the actual OD of the culture. 
The three different growth solutions for the growth curve analysis were made: 
High iron – Sauton’s ironfree with 150 µM FeCl3. 
Low iron – Sauton’s ironfree with 100 µM 2’2 dipyridyl 
Low iron 3 µM - Sauton’s ironfree with 3 µM FeCl3. 
Master mixes for each condition and mutant were made, for making three replica for each 
condition. It was mixed bacteria with the solution so the starting OD600, would be around 0.01. 
200 µl were inserted in each well in the growth curve plate. The growth curve machine, 
Bioscreen C MBR, was reading the OD600 evert second hour in three days.  
 
3.13 Freeze down of culture 
Freeze culture from the candidates chosen and used in the recombination project were made. 
By doing this these cultures would be stored and ready for more investigation at a later time 
point. This was done by freezing 1 ml of each culture grown for 3 days with 15 % glycerol in 
- 80°C. 
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4. Results 
4.1 Quality assessment of the M. avium transposon mutant library 
To knock out specific genes in M. avium is nearly impossible due to the low transformation 
efficiency in this bacterium. An organised M. avium transposon mutant library, where the 
insertion sites have been identified, will therefore be an invaluable tool to study mycobacterial 
gene function. An M. avium transposon mutant library containing 170 000 mutants was 
previously prepared by Marte Singsås Dragset. The library was constructed by transducing 
M. avium with the phagemid ϕMycoMarT7 (Figure 5), which inserts transposons randomly at 
TA dinucleotide sites [62]. In order to create a high-density mutant library, an M. avium strain 
which was especially susceptible to transposon mutagenesis by ϕMycoMarT7 was selected 
among 15 M. avium clinical isolates. Illumina transposon sequencing of the total library pool 
revealed that over 35 000 of the mutants in this library are unique, that is 35 000 different TA 
sites had a transposon insertion. The M. avium genome contains slightly more than 60 000 TA-
sites in the M. avium genome, meaning close to 60% of all TA sites were hit by a transposon 
(unpublished data). The library thus should consist largely of different transposon insertion 
mutants, and cover most of the non-essential genes in M. avium, even when taking into account 
that some genes contain more than one TA-site. 
 
4.1.1 Verification of transposon insertions 
To validate the quality of the replated library, the presence of the transposon was first verified 
for 10 random colonies by using PCR to check that the bacteria contained the gene for 
kanamycin resistance (Figure 11). The transposon contains this gene, but the wild type 
M. avium genome does not, so the presence of the kanamycin resistance gene will mean that 
the transposon is inserted in the bacterial genome. PCR primers for the kanamycin resistance 
gene were designed by using the software CloneManager. Before the PCR, colonies were 
picked and incubated for 3 weeks, bead beaten as described in section 3.3.1 and the DNA 
purified using MasterPure DNA Purification Kit from Epicentre. 10 colonies picked from an 
agar plate were checked with the primer pair Kan_F and Kan_R (Table 3 in section 3.1.3). 
Sample 4 was analysed twice because of no result first time analysed. When reanalysed sample 
4 also got a band (result not shown). Together, this shows that all the 10 randomly picked 
colonies have the kanamycin resistance gene.  
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Figure 11: Checking gene for kanamycin resistance.  
Gel electrophoresis of PCR product of the kanamycin resistance gene from 10 random colonies picked from agar. Ladder: 1 kb 
DNA ladder from NEB. Positive control: ϕMycoMarT7 as template. Negative control: water as template. 
 
4.1.2 Small scale identification of transposon insertion sites 
Next, to investigate if the transposon was inserted at different sites in the genome for the 9 of 
the 10 random mutant colonies, the genome sequence flanking the transposon was identified 
(Table 24). 
This was done by in-house Sanger-sequencing, with a primer that binds close to end of the 
transposon’s kanamycin gene. In this way, from the sequence generated, the end of the 
transposon could also be recognized before the avium genomic sequence starts, to ensure by 
sequencing as well that the transposon was present in the selected mutants.   
 
Table 24: Checking that the transposons are inserted in different genes. 
Since the M. avium strain used in the library is not published yet, the strain M. avium 104 was used as a reference genome when 
using BLAST. TGTTA are the 5 last base pairs of the transposon, and is here used as an indicator for insertion of the transposon. 
The TA-site is where the transposon insert in the genome. 
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The transposon sequence was found in each of the samples. Sample 2 and 10 have the 
transposon inserted in the same gene. The sequence of sample 4 was also good, but it did not 
match anything in NCBI BLAST.  
 
4. 2 Organising the M. avium library: Growing and pooling the mutants 
To be able to identify which well the mutant was originally grown in after all the mutants are 
analysed together in the Illumina sequencer, the mutants are pooled into plate, column and row 
pools. To separate different pools of samples, the different pools were coded. 
 
4.2.1 Preparation of the stock transposon insertion library for organisation 
In order to organise the pooled M. avium library, and identify transposon insertion sites, the 
library had to be replated. The M. avium genome consists of around 5100 genes. To maximize 
the chance of obtaining at least one mutant for each non-essential gene, a library size of around 
twice the size of the number of genes was decided upon for the organised library. Via plating 
of dilution series it was determined that the stock library suspension contained around 
3.9*1011 bacterial cells per ml. In order to use the Genetix QPixII colony picker, 2000 colonies 
per 23 cm x 23 cm agar plate is advisable. The stock suspension was therefore diluted to 
2000 bacteria/ml. Plating of 1 ml of the diluted suspension resulted in around 2000 colonies per 
plate, as seen in Figure 12. Initial testing had shown that at least 50 % of the colonies plated 
were accepted as pickable by the colony picker robot. 1 ml diluted suspension was therefore 
plated on each of a total of twelve 7H10 agar plates with 20 µg/ml kanamycin. This would 
ensure sufficient colonies to pick into 24 well plates consisting of 384 wells each, even if only 
half of the colonies were be accepted as pickable. 
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Figure 12: Agar plate showing a colony density suitable for robotic colony picking. 
For using the colony picker robot Genetix QPixII, it is advisable to have 2000 colonies per 23cm x 23cm agar plate. The goal 
was reached by diluting the library stock to 2000 bacteria/ml. By plating out 1 ml of this, around 2000 colonies grew up per 
plate. 
 
 
4.2.2 Colony picking robot 
Before pooling the plates, the replated colonies were picked into 384-well plates. It was decided 
to use the colony picking robot Genetix QPixII, to pick the colonies into the well plates. First, 
a  round of test-picking was done into one 384-well plate. This went well, the bacteria were 
growing in the complete 7H9 media with 20 µg/ml kanamycin in this plate after 3 weeks 
incubation at 37°C. The plate was covered with a sealing tape in addition to the respective lid 
of the well plate. The wells did not dry out and there was no sign of contamination. Thereby, 
9216 colonies were picked from the agar plates in duplicates into 48 plates with 384 wells each. 
Each duplicates was then consisting of 24 well plate. The library was picked in duplicates, so 
one library could be pooled and the other copy of the library could be stored and used to pick 
out interesting mutants later. The library was incubated at 37°C for 3 weeks, and then stored at 
4°C until pooling of the plates was done. 
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4.2.3 Pooling the plates 
The pooling strategy was to pool 3 µl every well at the same positions at every plate together 
in a master plate, and at the same time make two extra master plates, so that it would be enough 
material for DNA purification and preparation of DNA for Illumina sequencing. The master 
plates were pooled with help from the pipetting robot Freedom EVO 200 from TECAN. 10 µl 
of every well in each single plate were then manually pooled to create the plate pools.  To create 
column pools, 30 µl of every well in each single column in the master plates were manually 
pooled. The same applies for every row in the master plates, to create row pools. This strategy 
gave 24 plate pools, 24 column pools and 16 row pools. Each well is then represented three 
times - in a whole plate pool, a pool consisting of each well in each column and each row, as 
seen in Figure 13. 
Figure 13: Grinding the library in plate, column and row pools. 
3D pool organisation of 384-well plates. Each well is represented three times by this strategy – in a plate pool, in a row pool 
and in a column pool [63]. 
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4.3 Preparing the M. avium library pools for identification of transposon insertion sites 
by Illumina sequencing 
To separate different pools of samples, the primers and adapters used in the pool preparation 
contained indexes and barcodes, respectively. The adapter barcodes were used to define the 
number of plate, row and column pool, while the primer indexes referred to if the mutant was 
in a plate, row or column pool. In this way it was possible to identify which well the mutant 
was grown in originally, although all the pools are analysed in one single run in the Illumina 
sequencer.  
 
The genomic DNA from each of the 64 pools were isolated by bead beating and DNA 
purification with MasterPure DNA Purification Kit from Epicentre. The workflow for the 
preparation of the mutants consists of shearing, end-repair, A-tailing, adapter ligation and PCR 
amplification. This is described in section 1.4.2 and 3.11. 
 
4.3.1 Shearing genomic DNA 
Most of the samples were sheared enzymatically by fragmentase, which randomly creates 
double strand breaks in DNA [64]. The activity time of fragmentase was first optimised. It was 
desired to have fragments that were between 200 and 400 base pair. Therefore, 5 µg genomic 
DNA were incubated in the presence of  fragmentase in 0, 5, 10, 15, 25 and 30 minutes before 
inactivation of fragmentase by EDTA. Subsequently, the 5 µl of the sample were mixed with 1 
µl of Gel Loading Dye, Blue (6X) and the fragments were visualised by gel electrophoresis. As 
seen in Figure 14, an activity time of 25 minutes seemed to be the best. 
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Figure 14: Optimisation of the activity time for fragmentase. 
The activity time of fragmentase was optimised before it was used to shear the genomic DNA of transposon library mutants 
into smaller fragments. It was desired to have fragments that were between 200 and 400 base pair. Different time points were 
tested. From the gel electrophoresis done, an activity time of 25 minutes seemed to be the best. 
 
Due to unexpected lack of fragmentase, nine samples, four row pools and five column pools, 
were sheared by mechanical shearing by the instrument Covaris (Appendix 1 and 2). All 64 
samples were checked if they had the desired base pair length by gel electrophoresis after 
shearing (results not shown).  
 
4.3.2 End repair, A-tailing and adapter ligation 
In order to ligate adapters to the ends of the sheared DNA, the ends of the DNA fragments were 
first enzymatically blunt-ended using the end-repair kit from NEB (section 3.11.2).  To check 
if the fragments were blunt-ended, CloneJET PCR Cloning Kit from Thermo Scientific was 
used. This kit contains a blunt cloning vector, which is able to insert blunt ended DNA 
fragments. The vector contains a gene for ampicillin resistance and a gene that is lethal when it 
is not disrupted by ligation of a DNA insert into the cloning site [65]. By ligating end-repaired 
DNA fragments into this vector, transform it into bacteria and plate the transformation mix at 
LB-plates with 100 µg/ml ampicillin, it is possible to see if the DNA fragments were able to be 
inserted in the vector. At one plate it was plated bacteria that was transformed with vector with 
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the DNA fragments and at the other plate it was plated bacteria that was transformed with vector 
without the DNA fragments as a control. The plate with the bacteria transformed with DNA 
fragments inserted in vectors should have significantly more colonies grown up at the plates 
than the control plate. The test-plate had 100 colonies grown up and the control-plate had no 
colonies, which means that the after the end-repair step at least a fraction of the fragments 
should be end-repaired and ready for the next step: A-tailing, which is to add an extra A to the 
ends of the fragment (further explained in section 1.4.2). 
 
Successful A-tailing was check by using InsTAclone PCR Cloning Kit from Thermo Scientific. 
This kit contains a TA-cloning vector, which is able to insert dA-tailed DNA fragments. The 
vector contains a gene for ampicillin resistance and has a 3’ddT-overhang at each end. The 
transformed bacteria were plated at LB-plates with 100 µg/ml ampicillin. A control was also 
used here, which was made the same way as for the blunt end cloning. The test plate had over 
1000 colonies grown up and the control plate had around 100 colonies, which means that after 
the A-tailing step the fragments got an extra adenine added to their ends. 
 
4.3.3 Adapter ligation and coding the DNA pools 
To separate the mutants, they were coded with different adapters. Each adapter has a unique 
barcode. There will be one specific barcode for each number of the plates, columns and rows. 
In other words, the plate, column and row number 1, will all have the barcode number 1, then 
the plate, column and row number will all have barcode 2, and so on. Later on, with the PCR 
that will amplify the transposon junctions (section 4.3.4), the primers binding to the adapters 
will have indexes that will separate the mutants belonging to a plate, row or column 
(Sol_AP1_57, Sol_AP1_473, Sol_ AP1_100, respectively). This dual coding strategy is shown 
in Figure 15. 
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Figure 15: Strategy for coding the mutants. 
To separate the mutants, they were coded. First with 24 different adapters. Each adapter has a unique barcode. There will be 
one specific barcode for each number of the plates, columns and rows. Then the primers used will have barcodes that will tell 
if the mutant is in a plate, row or column. Colours in figure: Transposon is orange, genomic DNA is blue and adaptor is red. 
 
 
To check that the mutants were successfully adapter ligated, all the 64 adapter ligated samples 
were run in a small scale PCR by using the transposon binding primer Sol_Mar_NI and the 
adapter binding primer Sol_AP1_NI (Figure 16-18). This was done to check that they all had 
a smear, and not only formed dimers. Smears were expected because the since the fragments 
had been randomly sheared, and therefore had variable base pair lengths. Dimers would 
indicate that the transposon primer and the adapter primer had bond to themselves, and would 
be visualised as a band with length of around 100 base pair.  
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Figure 16: Gel electrophoresis of transposon junctions of all the plate pools amplified by small scale PCR. 
 
 
Figure 17: Gel electrophoresis of transposon junctions of all the column pools amplified by small scale PCR. 
 
Six column pools did not show smears as expected after the shearing by fragmentase (Figure 
17). These pools were therefore prepared over again, and this time sheared by Covaris. The 
pools then showed smears in the gel electrophoresis, which were in the desired base length 
region. 
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Figure 18: Gel electrophoresis of transposon junctions of all the row pools amplified by small scale PCR. 
 
Some of the samples were Sanger sequenced to confirm that the adapters were inserted in the 
transposon junction and had the correct barcode (Table 25). Before the samples were ready for 
Sanger sequencing, the samples had their transposon junctions amplified by PCR by using the 
transposon binding primer Sol_Mar_NI and the adapter binding primer Sol_AP1_NI. Then the 
transposon junctions were blunt cloned by CloneJET PCR Cloning Kit from Thermo Scientific. 
The transposon junction fragments were cloned into the vector pJET1.2 by following the 
protocol in section 3.1.7.2. 
The transposon junctions were then amplified by PCR again by using the primers Sol_Mar_NI 
and Sol_AP1_NI. The samples that had PCR-product would also be clones that had the 
transposon fragment inserted. This to ensure that the samples sent for Sanger sequencing most 
likely had the amplified PCR product inserted. The samples with PCR-product were then cut 
out of the gel and purified. The cloning vector’s respective sequencing primer, pJet1.2 forward 
sequencing primer, were mixed with the sample DNA before sequencing (section 3.8.1). The 
sequencing showed that the adapter barcodes corresponded to the sample sequenced, e.g. the 
samples sequenced from plate number 3 had the adapter barcode number 3. The results are 
shown in Table 25.  
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Table 25: Results from Sanger sequencing. 
Since the M. avium strain used in the library is not published yet, the strain M. avium 104 was used as a reference genome when 
using BLAST. TGTTA are the 5 last base pairs of the transposon, and is here used as an indicator for insertion of the transposon. 
Pool TGTTA Adapter 
BARCODE 
Blast GENE 
Plate 9 Yes 9 - 
Plate 9 Yes 9 - 
Column 3 Yes 3 - 
Column 15 Yes 15 Pyrioxamine 5’-phosphate oxidase 
family protein 
Row 9 Yes 9 - 
Row 9 Yes 9 Conserved hypothetical protein 
Row 15 Yes 15 Anti-anti-sigma factor 
Row 15 Yes 15 - 
 
4.3.4 PCR of adapter ligated plate, column and row DNA pools 
PCR was done to add the Illumina attachment and read homology. Before the PCR, all the plate 
pools were pooled together, making a master plate pool. Master pools were also made for all 
the column pools and the row pools. PCR with the transposon primer mix and the pools 
respective adapter primers was done 10 to 11 times for each of the three pools now remaining. 
For protocol see section 3.6.4. The PCR was done several times to ensure that only some 
fragments were amplified. The PCR products were run at a gel and the fragments from 200 to 
400 base pair were cut out of the gel and the DNA purified. See figure 19 and 20, and Appendix 
3 and 4. 
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Figure 19: Gel electrophoresis of PCR-products where all the pools in each category plate, column and row are pooled. 
 
 
Figure 20: Gel from figure 19, after cutting out bands with approximately length of 200 to 400 base pairs.  
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The PCR-products of the master pools were purified and the products that were from the same 
kind of pool were pooled. The fragments in the three remaining pools were then visualised by 
gel electrophoresis. Quite sharp bands were seen (Figure 21). The formation of sharp bands had 
also been seen for some of the samples in the small scale PCR tests in Figure 16-18. Sharp 
bands on the PCR could indicate contamination, that one specific fragment was amplified 
instead of a smear of different sized fragments. Therefore, the samples were analysed by a 
BioAnalyzer also to ensure that samples were not contaminated. The results from the 
BioAnalyzer showed smears and also acceptable base pair lengths for Illumina sequencing 
(Figure 22 and 23). Around 25 ng in 30 µl was then sent to Texas A&M University for Illumina 
sequencing from each of the three final pools.  
 
 
Figure 21: Gel electrophoresis of the final pools of plates (P), columns (C) and rows (R).  
In the three first sample lines 1 µl DNA of the final pools of plates (127 ng/µl), columns (87 ng/µl), and rows (104 ng/µl) was 
loaded. In the three last sample lines 3 µl of the same samples were loaded on the gel. 
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Figure 22: Results from BioAnalyzer, showing smears from shearing the final plate, column and row pool with Covaris. 
L-lane is showing the ladder with base pair lengths annotated. Lane 1 is the column pool, lane 2 is the row pool and lane 3 is 
the plate pool.  
 
 
 
Figure 23: Electropherogram from BioAnalyzer, showing the distribution of DNA in the final column, row and plate 
pool. 
The first electropherogram is the DNA distribution in the column pool, the second is the row pool and the last one show the 
DNA distribution of the plate pool. The DNA distribution is shown in relation to the base pair (bp) length of the DNA in the 
sample, which is represented with the x-axis. The y-axis of the electropherogram represents fluorescence units (FU). The two 
high peaks in each electropherogram are markers, and not part of the DNA sample. 
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4.4 Creating knock-out of the genes msmeg_4898 and msmeg_4900 by homologous 
recombination 
Iron uptake is an important field in mycobacteria research because one of the ways the 
M. tuberculosis survives intercellularly is by having mechanisms to take up iron when there are 
extremely low iron conditions [18]. M. smegmatis, as opposed to M. avium, is susceptible to 
homologous recombination: This method was therefore used to knock out the genes 
msmeg_4898 and msmeg_4900 in M. smegmatis. These genes were genes potentially related to 
iron uptake in mycobacteria, because of homology to genes in M. tuberculosis laying in a cluster 
of genes known to be involved in iron uptake [32]. The M. tuberculosis homologue to 
msmeg_4898 is in addition predicted to be a binding site for IdeR (iron-dependent regulator, 
and this gene in M. tuberculosis is also shown to be repressed by the presence of iron and 
IdeR [33-35].  
Four bacteria cultures of M. smegmatis were started; the wild type (WT), a mycobactin knock-
out mutant (ΔmbtD), an exochelin knock-out mutant (ΔfxbA) and a double knock-out mutant, 
where both mycobactin and exochelin are knocked out (ΔmbtD_ΔfxbA). ΔmbtD is a polyketide 
synthase required for the synthesis of mycobactin and ΔfxbA is a formyl transferase involved 
in the synthesis of exochelin [66, 67]. By knocking down genes involved in synthesis of a 
siderophore, the mutant is no longer able to produce the siderophore. Knock-out mutants of the 
genes msmeg_4898 and msmeg_4900 were made in all of the four different strains. This was 
done to be able to see how this knock-out mutation would affect the growth of the strains, and 
be able to identify which siderophore pathway the genes msmeg_4898 and msmeg_4900  might 
were a part of. By combining mutations in the two different iron uptake pathways the bacteria 
should fail to grow under low iron conditions. By combining mutations in the same iron uptake 
system, the bacteria should still be able to grow under low iron conditions, as it would be 
rescued by the intact siderophore.  
All these bacteria contained the recombination plasmid pJV53. They were induced by actemide 
and homologeously recombined with a construct consisting of a gentamicin resistance gene 
between 200 base pair flanking the genes msmeg_4898 and msmeg_4900. The recombined 
bacteria were then plated at 7H10 agars with 7.5µg/ml gentamicin and incubated for 3 days.  
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4.4.1 Selecting knock-out mutants for growth curve analysis 
The mutants correctly recombined was found by using four pairs of primer set (Figure 24). The 
names and where they bind are shown in Figure 25. The expected results of bands in gel 
electrophoresis after PCR amplification for successful knock-out are seen in Table 26. In Table 
27 the primer pair and their respective length of their PCR-product are shown.   
 
Figure 24: Four set of primer pairs were used to confirm knock out of the genes msmeg_4898 and msmeg_4900. 
WT stand for the wild type, and KO for the knock-out mutant. 
 
 
Figure 25: Primer pairs used to confirm knock-out of the genes msmeg_4898 and msmeg_4900.  
A scheme over where the different primer pairs used to confirm  knock-out of the genes msmeg_4898 and msmeg_4900 and 
were these primers would bind at the wild type (WT) and the knock-out mutants (KO).This scheme also shows the names of 
the primers. 
 
 
Table 26: Expected results of successful knock-out mutants at gel electrophoresis after PCR. 
 Primer pair 1 Primer pair 2 Primer pair 3 Primer pair 4 
Band at all 
candidates 
Yes No No Yes 
Band at 
control,  
M. smegmatis 
No Yes Yes No 
 
 
  
RESULTS 
53 
 
Table 27: The primer pairs used to confirm knock-out of the genes msmeg_4898 and msmeg_4900 and the length of 
their PCR-products. 
Primer pair Base pair length of PCR-product 
1. 4898_WT_F + GENT_KO_R 853 
2. 4898_WT_F + 4898_WT_R 684 
3. 4898_WT_UP_F + 4898_WT_UP_R 824 
4. 4898_WT_UP_R + GENT_KO_F 1128 
 
First DNA from four colonies from each category WT, ΔmbtD, ΔfxbA and ΔmbtD_ΔfxbA were 
amplified using primer pair 1. A successful mutant would here show a band using this primer 
pair, indicating that the gentamicin resistance gene is inserted. The WT-category had one with 
a weak band. All the mycobactin knock-outs checked had bands. Half of the exochelin knock-
outs had bands, and all the double knock-outs checked got bands. The control used, genomic 
DNA from M. smegmatis that had not been recombined (100 ng/µl), showed no bands as 
expected. One candidate with band was chosen from each category for further check with the 
other primer pairs. The candidates chosen is indicates by an asterisk in Figure 26.  
 
Figure 26: Gel electrophoresis of products from PCR with primer pair 1 to confirm knock-out of the genes 
msmeg_4898 and msmeg_4900. 
One candidate with band was chosen from each category for further check with the other primer pairs. The candidates chosen 
is shown with a *. The control used, M. smegmatis that had not been recombined, showed no bands as expected. WT is wild 
type, ΔM is mycobactin knock-out mutant, ΔF is exochelin knock-out mutant and Δ/Δ is a mutant with both mycobactin and 
exochelin knocked out. 
 
The chosen candidates from the run with primer pair 1, were then tested with primer pair 2, 
primer pair 3 and primer pair 4. As seen in Figure 27, the results for primer pair 2 and 3 were 
as expected. For primer pair 4 the control was as expected, and the double knock-out also got a 
clear band. However, only weak bands were shown for ΔmbtD and ΔfxbA, and there was no 
band to see for the wild type. PCR with primer pair 4 was thus repeated and correct mutants 
were identified, although, for the msmeg_4898-4900 mutant in the WT background, new 
colonies had to be analysed before a correct mutant was identified (results shown in Appendix 
5 and 6).  
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Figure 27: Gel electrophoresis of products from PCR with primer pair 2, 3 and 4 to confirm knock-out of the genes 
msmeg_4898 and msmeg_4900. 
WT is wild type, ΔM is mycobactin knock-out mutant, ΔF is exochelin knock-out mutant and Δ/Δ is a mutant with both 
mycobactin and exochelin knocked out. The control used is M. smegmatis that had not been recombined. 
 
4.4.2 Growth of msmeg_4898 and msmeg_4900 knock-outs under low iron conditions 
In order to assess the potential function of msmeg_4898 and msmeg_4900 in mycobactin-
mediated iron uptake, the msmeg_4898-4900 knockout mutants were prepared for growth curve 
analysis. There was made high and low iron conditions for all the candidates, and each condition 
was set up with three technical replicates in the well plate for the growth curve instrument, 
Bioscreen C MBR. The OD600 was read every second hour in three days by Bioscreen C MBR. 
This experiment was repeated three times.  
If the bacteria do not grow at low iron conditions when exochelin and the genes msmeg_4898 
and msmeg_4900 studied are knocked-out it indicates that the genes studied are important for 
the mycobactin pathway. With exochelin knocked out, mycobactin is the siderophore to take 
up iron. If genes that are important for the mycobactin pathway also are knocked-out, the 
bacteria do not have any functional siderophore iron uptake system, and therefore lose an 
important way to take up iron from the outside of the cell. Since iron is crucial for the growth 
of the bacteria, the bacteria will fail to grow under low iron conditions [30]. 
As seen in Figure 28, it is seen that the bacteria are still growing under low iron conditions, 
although exochelin and the genes msmeg_4898 and msmeg_4900 are knocked out in the same 
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mutant. Similar results are shown in the two other growth analysis done (Appendix 7 and 8). In 
the growth curves shown in Figure 28 is the msmeg_4898 and msmeg_4900 knock out called 
Δ4898.  The ΔfxbA_Δ4898 is growing less than the ΔfxbA at low iron conditions. However the 
same trend is seen at high iron conditions. The WT and the WT_Δ4898 are growing similarly 
under low iron conditions, and this is also seen under high iron conditions for WT and the 
WT_Δ4898. Similarly are the results for ΔmbtD and ΔmbtD_Δ4898. In addition, the 
ΔmbtD_ΔfxbA and the ΔmbtD_ΔfxbA_Δ4898 are growing similarly under low iron (3µM iron 
added) conditions and also under high iron conditions. Thus, it seems like msmeg_4898 and 
msmeg_4900 is not required for iron uptake in M. smegmatis.  
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Figure 28: The first replicate of growth curve analysis. 
In order to assess the potential function of msmeg_4898 and msmeg_4900 in mycobactin-mediated iron uptake, the 
msmeg_4898-4900 knockout mutants (Δ4898) were prepared for growth curve analysis. There was made high and low iron 
conditions for all the candidates, and each condition was set up with three technical replicates in the well plate for the growth 
curve instrument, Bioscreen C MBR. The OD600 was read every second hour in three days by Bioscreen C MBR. This 
experiment was repeated three times. The four bacteria candidates of M. smegmatis analysed, both with and without the genes 
msmeg_4898 and msmeg_4900 knocked out were; the wild type (WT), a mycobactin knock-out mutant (ΔmbtD), an exochelin 
knock-out mutant (ΔfxbA) and a double knock-out mutant, where both mycobactin and exochelin are knocked out 
(ΔmbtD_ΔfxbA).  
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5. Discussion 
 
In this study, it is shown how it is possible to identify the mutated genes in a large M. avium 
transposon mutant library by using Illumina sequencing. To have a transposon library of 
M. avium is of special worth, because this species is not that susceptible to mutagenesis by 
homologous recombination due to low transformation efficiency (Marte Dragset, personal 
communication). Therefore, the library would be a good resource for pick out mutant to study 
gene function in M. avium, and new discoveries might be transferable to M. tuberculosis gene 
function. M. smegmatis is susceptible to mutagenesis by homologous recombination [50]. Due 
to an efficient transformation efficiency M. smegmatis is useful as a model to study 
mycobacterial basic mechanisms, including uptake of iron [30]. Therefore, to study their 
proposed role in mycobacterial iron uptake, two M. smegmatis genes suggested to be involved 
in uptake of iron were knocked out by recombineering. Their requirement for mycobacterial 
growth in low iron was subsequently investigated.  
 
5.1 Transposon mutagenesis versus homologous recombination 
There are positive and negative sides by using transposon mutagenesis. And there are also 
advantages and disadvantages by using homologous recombination. Transposon mutagenesis 
is efficient in the way that it is a not that much work needed to make mutations evenly 
distributed all over a genome. Due to this, transposon mutagenesis is a great technique for 
creating mutant libraries. By homologous recombination just a few genes, which then are next 
to each other, can be mutated in one round of mutagenesis done in the laboratory. Furthermore, 
by homologous recombination the genes mutated can be deleted from the genome. By 
transposon mutagenesis, the sequence of a gene will still be in the genome, just disrupted by 
the transposon. Consequently, depending on where in the gene the transposon is inserted, the 
function of the gene can still be intact. The insertion of the transposon can also lead to an 
uncontrolled altered function of the gene disrupted. However, most mutations by transposons 
lead to a total inactivation of the gene [68]. 
Which gene that is mutated, is easy to control by homologous recombination. However, it is 
also possible to do targeted mutagenesis by transposons that bind to defined DNA-binding 
domains [69]. Both transposons and homologous recombined genes can be designed to carry 
selectable markers, such as antibiotic resistance. Due to this it is easy to find mutated bacteria, 
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by using phenotypic screening for example for antibiotic resistance. However, some times the 
recombination can occur at a not desired place in the genome. 
Sometimes also just a part of the gene that is desired to knock-out is recombined. Therefore, it 
is important to control for appropriated recombination by PCR, as done in this thesis, to ensure 
that the whole targeted gene sequence actually is deleted in the recombined version of the 
genome. Transposon mutagenesis can to some extent be controlled. Transposons can be inserted 
in a desired DNA-binding domain, but can also be inserted randomly in a genome independent 
of specific nucleotides [40, 69, 70]. The transposon used in this thesis only inserted at TA-sites. 
Consequently, genes which do not have any TA-site would not be mutated. Due to the even 
distribution of mutations, essential genes can be easily discovered by transposon mutagenesis. 
When the transposon is inserted in an essential gene, the bacteria with this insertion would not 
grow.  
 
5.2 Identification of transposon insertion site by Sanger sequencing 
During the preparation of the M. avium transposon library, Sanger sequencing was used on 
several occasions to check that transposon mutants. Although transposons were detected in the 
random mutants investigated, both by PCR and by Sanger sequencing, not all of them matched 
the M. avium 104 reference genome, or any other sequence on NCBI BLAST. One possibility 
here is that this is a gene that is typical for the strain used in the library, which is sequenced, 
but not published yet. The transposon can also have been inserted in a mycobacterial plasmid 
without known sequence.  
As shown in Table 24 in section 4.1.2, results from this Sanger sequencing were showing that 
the transposon was inserted in the same gene in two of the nine mutants investigated. This could 
mean that some mutants are highly overrepresented in the library, which would result in a 
library that would not give a desired coverage of the genome.  
It statistical unlikely that for two of nine samples investigated the transposon should be inserted 
in the same gene, since the library consists of 35 000 unique mutants, where all had transposon 
inserted at different TA-sites. The bacterium mutated has around 5000 genes. This seems to be 
a coincidence that two of the mutants had the transposon inserted in the same gene, while the 
gene they were inserted in has not shown up in the other Sanger sequencings done. It could be 
that by coincidence two mutants for the same gene were picked. Another explanation would be 
that two samples were mixed or one mutant was picked twice from the agar plate.   
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The other results from the sequencing to control that the transposon was inserted in different 
genes in the transposon library, were as it was hoped for. Most of the genes were inserted in 
different genes and the transposon was identified in all mutants.  
In the other Sanger sequencings done, it is sometimes seen that the genome sequence detected 
is very short. This was the example for the majority of the samples listed in Table 25. In this 
case, PCR products were ligated into a blunt vector, transformed and prepared for sequencing.  
The reason for the short sequence could be due to that the vector prefer to insert the short 
fragments in comparison to the longer fragments. Anyway, the results from the Sanger 
sequencing, including additional results not shown in this thesis,  showed that over 50% of the 
fragments analysed were as expected after preparation for Illumina based transposon 
sequencing. The remaining 50 % was fragments that didn’t have the transposon, adapter or 
genomic DNA inserted. It was concluded that this would be sufficient for a successful Illumina 
sequencing of the library.  
 
5.3 Preparation of the transposon library mutant pools for Illumina sequencing 
During the preparation of the transposon library mutant pools for Illumina sequencing, there 
were some problems getting enough DNA by using the MasterPure kit. This might have been 
better by using another method to isolate the DNA, e.g. by phenol-chloroform extraction. 
However, using phenol-chloroform extraction would be more time consuming and laborious, 
and would include the use of an organic solvent and a dangerous corrosive chemical. In the end 
of the preparation period, some of the original bacteria sample pools started to run empty, due 
to that the fragmentase step had to be repeated several times for some samples to get the desired 
fragment length. Therefore a small portion of the bacteria culture from each of these pools was 
diluted 1:10 in 5 ml 7H9 Complete and incubated in 5 days before the purification of DNA to 
increase the number of bacteria before isolating. To increase the amount of bacterial in each 
pool by had a good effect on the DNA amount got after MasterPure purification. Therefore, in 
a retrospective view, it might have been better to do this for all the samples from the beginning. 
The reason why not all the sample pools were incubated some days longer after they were 
pooled and before the purification of DNA from the beginning was because of fear of that a few 
of the mutants would grow faster than others dominate the pool completely. However, it should 
not be problematic, because this method do not count on amount of each mutant, but its presence 
or absence.  
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When fragmenting the DNA, the activity time of fragmentase, which enzymatically sheared the 
purified DNA, was optimised to reach the desired fragment lengths. However, even with 
optimisation, the DNA purified from the various 64 pools often showed too small or too large 
DNA fragments after shearing compared to the desired, optimised length. This could be due to 
different purity of DNA in the samples, or that the DNA concentrations measured by NanoDrop 
was not precise. By mechanical shearing though, a desired length of the fragments was much 
easier to control. Mechanical shearing was not used from the start due to that this method is 
more expensive than shearing with fragmentase. However, thinking of all the work with redoing 
the fragmentase shearing due to incorrect fragment size in many of the DNA pools, it seems to 
be a better approach to use mechanical shearing to shear the DNA. 
During the testing of adapter ligation, it was by several occasions seen sharp bands after 
amplification of the transposon junction by PCR, when visualised by gel electrophoresis. It was 
expected to see smears here, which would indicate the presence of several different fragments 
in the pool. Sharp bands could represent primer-dimers, amplification of just a few specific 
fragments during PCR amplification or contaminations. Therefore, the final three samples were 
also analysed on BioAnalyzer before the samples were sent to Texas A&M University for 
sequencing. The results from the BioAnalyzer showed smears, but with a different fragment 
size distribution in the three different final pools. From the gel electrophoresis results obtained 
in the gel, which the DNA from the master pools where purified from, it looked as the samples 
had around the same fragment size distributions. The fragments in the three final pools, which 
were also analysed on BioAnalyzer, were also visualised by conventional gel electrophoresis. 
This time it was loaded less DNA than done in the gel electrophorese done for cutting out the 
desired fragment length from the gel, and quite sharp bands were seen, and the bands were 
sharpest at the highest concentration of DNA. In addition, the fragment size distribution in the 
three final pool showed the same as the results from the BioAnalyzer. By this it looks as the 
DNA in gels with GelRed run different in the gel when high concentrations of DNA are loaded 
at the gel. Therefore, it would might be better colour the gel after gel electrophoresis, than 
having GelRed in the gel before running DNA samples.  
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5.4 Potential results from Illumina sequencing and their reliability  
All the steps in the preparation of the transposon library to make it ready for Illumina 
sequencing were checked after each step was done, to ensure  the Illumina sequencing to give 
readable and trustworthy sequencing results. However, it will always be chances for that 
contamination will give wrong results. In this case, it could be if some bacteria that not belong 
to a pool, accidently got into a wrong pool. For example was the sealing tape that was put on 
the wells before the incubation sometimes difficult to put on and also to take off. Although 
these sealing tapes were handled with extreme care when taking them on and off the well plates, 
the difficulties could have led to contamination between the wells. Other steps that could have 
led to contamination are that DNA not belonging to the library contaminated the library DNA 
and was then amplified by PCR. It could also be that some residue from the phagemid used to 
insert the transposon into the bacteria was still left in the library stock, and then sequences from 
the phagemid can be found in the Illumina sequencing. However, Sanger sequenced test 
samples have not matched the phagemid in NCBI BLAST.  
When the results from the Illumina sequencing in Texas is ready at the end of June 2015, some 
wells are expected to have no results because of that they went dry during the incubation time. 
If there is two or more mutants in the library, which have their transposon insertion in the same 
TA-site in the genome of M. avium, several combinations of coding would be available for 
these identical mutants, which would make it difficult to trace back to the original well position.  
The newly published article in Nature Communications by Vandewalle et al., describes a 
similar approach to organise a transposon mutant library and identify them by Illumina 
sequencing as done in this study. The article describes how this is done in M. bovis [58]. By 
looking at their results it is therefore possible to say something about what is expected of results 
from the library organised and prepared in this study.  
Vandewalle et al. found that in their library 64% of the non-essential M. tuberculosis 
orthologues were disrupted. Over 77% of the 8259 unique TA-sites in M. bovis had sufficient 
sequence coverage for the software used to identify the position of the gene in the organised 
library. Around 84% of the mutations were in known genes, which means 57% of  the genes in 
the genome of M. bovis were mutated. By testing around 100 of 9216 well positions if the 
mutants in the specific wells matched the mutants given by Illumina sequencing, all the wells 
checked had matching mutations with the sequence that the position should have according to 
the Illumina sequencing results. They also assume that if the number of wells with mutants were 
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doubled, 90% of the genes that is possible to target by transposon mutagenesis would the 
covered in the library [58]. 
With an organised transposon library organised it is possible to perform large-scale screenings 
and study the phenotype of all or several mutants in the library at the same time. It is also 
possible to pick out a few genes of interest, e.g. genes that might be related to iron uptake. After 
the desired mutant has been isolated, its phenotype can be studied, e.g. to investigate how the 
mutant will grow in media with low and high content of iron.  
 
5.5 The putative role of msmeg_4898 and msmeg_4900 in mycobacterial iron uptake.  
The gene cluster esx-3 was found to be required for mycobactin-mediated iron uptake by 
combining mutations in the two different iron uptake pathways. It was indicated that the gene 
cluster esx-3 is important for the mycobactin pathway by that the mutant strain where exochelin 
and esx-3 were knocked out failed to grow at low iron conditions [30]. This pattern would also 
be expected to see if the gene msmeg_4898 and msmeg_4900 is a part of the mycobactin 
pathway in M. smegmatis.  
From the growth curves seen in Figure 28 and Appendix 7 and 8, it is seen that the WT and the 
WT_Δ4898 are growing similarly under low iron condition, and this is also seen under high 
iron conditions for WT and the WT_Δ4898. Also for the ΔmbtD and the ΔmbtD_Δ4898 is it 
seen similar growth curves under low iron condition, and the same under high iron conditions. 
This indicates that the genes msmeg_4898 and msmeg_4900 are not a part of the exochelin 
pathway, because the exochelin pathway here saves the ΔmbtD_Δ4898. The ΔmbtD_Δ4898 
would not grow if it was a part of the exochelin pathway, due to the fact that both siderophore 
pathways then would be knocked out. 
In contrast to the double knock-out of exochelin and esx-3, the double knock-out ΔfxbA_Δ4898 
is still growing under low iron conditions. However, the ΔfxbA_Δ4898 is growing less than the 
ΔfxbA at low iron conditions. This could indicate that msmeg_4898 and msmeg_4900 are 
important for iron uptake under low iron conditions. Nevertheless, since the same trend is seen 
at high iron conditions, the conclusion about msmeg_4898 and msmeg_4900 being important 
for mycobactin pathway cannot be taken. 
The ΔmbtD_ΔfxbA and the ΔmbtD_ΔfxbA_Δ4898 are growing similarly under low iron (3 µM 
iron added) conditions and also under high iron conditions. If the ΔmbtD_ΔfxbA had been 
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growing better than the ΔmbtD_ΔfxbA_ Δ4898 on low iron levels, it would have indicated that 
msmeg_4898 and msmeg_4900 is a part of another iron uptake system that would take over the 
iron acquisition when the siderophore pathways do not work.  
Although, it seems to be no important role for the genes msmeg_4898 and msmeg_4900 in the 
mycobactin pathway, the true role of the genes could be masked if the 200 base pairs flaking 
sites of the genes, if these are enough to maintain the iron uptake function of the genes. 
An interesting observation was made when the mutant colonies from the original agar plates 
were plated on LB-plates without additional iron. The knock-out mutants didn’t grow on these 
plates. However, they grew on 7H10-plates with 7.5 µg/ml gentamicin 150 µM FeCl3.This 
could be due to that the bacteria without the genes msmeg_4898 and msmeg_4900 are essential 
to iron. However, it could be that the bacteria for reasons unknown do not like one or several 
ingredients in LB-agar, or that the agar lacks one or several important ingredients. The 
assumptions about  the LB-agar are here most likely, due to the fact that the mutants were 
growing under low iron conditions during the growth curve assay. 
 
5.6 Summary/ Conclusion 
In this study, it is shown how it is possible to identify the mutated genes in a large M. avium 
transposon mutant library by using Illumina sequencing. However, it will not be possible to tell 
if this approach was successful before the sequencing results are available at the end of June 
2015. Since all the quality checks during the preparation have been positive, it is likely that the 
results from the Illumina sequencing will allow to link mutants and sequences, thereby 
generating the desired mutant library for future research. The approach will then also be able to 
be used for generating other mutant libraries. 
The genes msmeg_4898 and msmeg_4900 do not seem to be important for the mycobactin 
pathway in M. smegmatis. This does not mean that they are not important for this purpose in 
other mycobacteria.  
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5.7 Further perspectives 
Depending on the results from the Illumina sequencing, there will be different further 
perspectives. If the sequencing results do not allow to link the sequencing reads to specific 
mutants, error searching has to be done. It could also be interesting if samples that were grown 
more before DNA purification and were sheared mechanically instead of enzymatically would 
have different outcome shown through the sequencing.   
If the sequencing is successful, this library will be a valuable tool in research. Future use of the 
library would be to use it to pick out mutants of interest to investigate. With this library it will 
also be possible to conduct screenings with many thousand mutants at the same time and study 
their phenotype under different conditions.  
The homologues of the genes msmeg_4898 and msmeg_4900 would be of interest to study also 
in M. avium and M. tuberculosis, to see the importance of the homologous genes in iron uptake 
in these mycobacterial species. The homologous genes in M. avium and M. tuberculosis, could 
be important although the genes msmeg_4898 and msmeg_4900 are not important in 
M. smegmatis. For example, M. smegmatis could have developed another system for 
transporting mycobactin over the outer membrane in the cell wall, than other mycobacteria. To 
study the homologues of the genes msmeg_4898 and msmeg_4900 in M. avium, the organised 
transposon library would be of great value, due to the fact that M. avium is not susceptible for 
mutagenesis through recombination.
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7. Appendices 
 
Appendix 1: Gel electrophoresis that checks the fragment length of the column pools 
after being sheared with Covaris. 
 
 
Appendix 2: Gel electrophoresis that checks the fragment lengths of the row pools 
after being sheared with Covaris. 
 
The row pools tested here are number 6, 7, 12 and 13. In front of every lane with the Covaris-sheared fragment, is unsheared 
DNA from each respective row pool loaded.  
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Appendix 3: Gel electrophoresis of PCR-products where all the pools in each category 
plate, column and row are pooled. 
 
 
Appendix 4: Gel from Figure 20, after cutting out bands with approximately length of 
200 to 400 base pairs.  
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Appendix 5: Gel electrophoresis of products from PCR with primer pair 2, 3 and 4 to 
confirm knock-out of the genes msmeg_4898 and msmeg_4900. 
 
WT is wild type, ΔM is mycobactin knock-out mutant, ΔF is exochelin knock-out mutant and Δ/Δ is a mutant with both 
mycobactin and exochelin knocked out. The control used is M. smegmatis that had not been recombined. 
 
Appendix 6: Gel electrophoresis of WT PCR-products from PCR with primer pair 1, 2, 3 
and 4 to confirm knock-out of the genes msmeg_4898 and msmeg_4900. 
 
This was done to find a WT-candidate. WT3 was the candidate chosen. WT is wild type, ΔM is mycobactin knock-out 
mutant, ΔF is exochelin knock-out mutant and Δ/Δ is a mutant with both mycobactin and exochelin knocked out. The control 
used is M. smegmatis that had not been recombined. 
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Appendix 7: The second replicate of growth curve analysis. 
  
In order to assess the potential function of msmeg_4898 and msmeg_4900 in mycobactin-mediated iron uptake, the 
msmeg_4898-4900 knockout mutants (Δ4898) were prepared for growth curve analysis. There was made high and low 
iron conditions for all the candidates, and each condition was set up with three technical replicates in the well plate for the 
growth curve instrument, Bioscreen C MBR. The OD600 was read every second hour in three days by Bioscreen C MBR. 
This experiment was repeated three times. The four bacteria candicates of M. smegmatis analysed, both with and without 
the genes msmeg_4898 and msmeg_4900 knocked out were; the wild type (WT), a mycobactin knock-out mutant (ΔmbtD), 
an exochelin knock-out mutant (ΔfxbA) and a double knock-out mutant, where both mycobactin and exochelin are knocked 
out (ΔmbtD_ΔfxbA).  
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Appendix 8: The third replicate of growth curve analysis. 
 
In order to assess the potential function of msmeg_4898 and msmeg_4900 in mycobactin-mediated iron uptake, the 
msmeg_4898-4900 knockout mutants (Δ4898) were prepared for growth curve analysis. There was made high and low 
iron conditions for all the candidates, and each condition was set up with three technical replicates in the well plate for the 
growth curve instrument, Bioscreen C MBR. The OD600 was read every second hour in three days by Bioscreen C MBR. 
This experiment was repeated three times. The four bacteria candicates of M. smegmatis analysed, both with and without 
the genes msmeg_4898 and msmeg_4900 knocked out were; the wild type (WT), a mycobactin knock-out mutant (ΔmbtD), 
an exochelin knock-out mutant (ΔfxbA) and a double knock-out mutant, where both mycobactin and exochelin are knocked 
out (ΔmbtD_ΔfxbA).  
 
